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ANALYSIS OF IMPACT OF MISSING DATA IN THE STUDY OF RACIAL 
DIFFERENCES IN ENDOMETRIAL CANCER SURVIVAL 
Xinxin Dong, M.S. 
     University of Pittsburgh, 2009 
Endometrial cancer is the third most common cause of gynecologic cancer death and shows the 
largest overall survival difference (34%) between the races.  The National Cancer Institute (NCI) 
Black/White Cancer Survival Study was a population-based study of racial differences in cancer 
survival.  Endometrial cancer cases consisted of 149 black women, ages 20-79 years, residing in 
three selected metropolitan areas, who were diagnosed with endometrial cancer between 1985 
and 1987. Cases were frequency matched in a ratio of approximately 1:2 to a sample of 341 
white women with endometrial cancer.  Information was derived from abstracts of hospital and 
physicians’ records, centralized pathology review, and interviews.  Potential explanatory factors 
for black-white survival differences have been previously investigated using Cox regression.  
However, there was a high proportion of missing values since 24 percent of patients were never 
interviewed.  Some values were also missing for three other variables derived from medical 
records. Missing values may introduced bias in previous findings based only on the information 
available. 
The primary objective of this thesis is to evaluate the effect of missing data on the 
estimated black/white mortality ratios adjusted for various explanatory factors.  A second 
objective is to obtain more precise confidence intervals for the estimated mortality ratios.   
Nearest neighbor hot deck imputation has been used to generate fifty “complete” datasets.  
Adjusting for age and geographic location, the black/white mortality ratio for the imputed 
datasets was 3.3.   When adjusted for all covariates, the mortality ratio was only 1.2.  Overall, 
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87% of the excess mortality could be attributed to racial differences in disease stage, tumor 
characteristics, treatment, sociodemographic characteristics, hormonal and reproductive factors, 
the number of comorbidities and health behavior.   
The results based on multiple imputation indicate that missing data did not introduce 
major bias in the earlier analyses.  However, multiple imputation provided narrower confidence 
intervals than those obtained previously.  Multiple imputation was worthwhile since it gave more 
precise estimates for the relative mortality ratios.   
These findings have public health importance: they have implications for development of 
health policies and planning interventions to reduce the excess risk of death among black women 
with endometrial cancer. 
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1.0  INTRODUCTION 
Endometrial cancer refers to several types of malignancy, which arise from the 
endometrium or lining of the uterus.  It is the most common gynecologic cancer in the 
United States.  The most common subtype is endometrioid adenocarcinoma, which 
typically occurs within a few decades of menopause, and is associated with excessive 
estrogen exposure.  This subtype often develops in the setting of endometrial hyperplasia, 
and presents most often with vaginal bleeding.  It comprises about 75 to 80% of all 
endometrial cancers.  The second most common form is papillary serous 
adenocarcinoma, which comprises about 10% of all endometrial cancers, and another 
form is clear cell adenocarcinoma (about 4-5% of all endometrial carcinomas).  Both 
papillary serous and clear cell adenocarcinomas tend to be more aggressive than 
endometrioid adenocarcinomas, and are often detected at advanced stages.  Sometimes an 
endometrial cancer has features of more than one subtype; this is called a mixed 
adenocarcinoma and they make up about 10% of all endometrial cancers.  There are a 
few other rare types like mucinous adenocarcinoma and squamous cell adenocarcinoma 
that each compromise less than 1% of endometrial cancers (Dolinsky, 2008). 
Endometrial carcinoma is the third most common cause of gynecologic cancer 
death (after ovarian and cervical cancer).  On January 1, 2005, in the United States there 
were approximately 572,626 women alive who had a history of cancer of the corpus and 
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uterus.  In 2008, there are 40,100 new cases and 7,470 deaths from endometrial cancer in 
the United States (Ries et al., 2008). 
There is a significant observed black/white differential in endometrial cancer 
survival.  The incidence rate for African American women is 20.3 per 100,000 women 
and for Caucasian women is 24.3 per 100,000 women based on cases diagnosed in 2001-
2005 from 17 SEER (Surveillance, Epidemiology, and End Results) geographic areas.   
However, the mortality rate is 3.9 per 100,000 white omen, and 7.1 per 100,000 black 
women, based on patients who died in 2001-2005 for the United States.  Five-year 
relative survival rates for 1996-2004 from 17 SEER geographic areas were: 84.7% for 
white women and 61.1% for black women.  For both races, 1.31% of women will 
develop endometrial cancer between their 50th and 70th birthdays based on the rate from 
2003-2005.  Decreases in mortality rates were observed for both races between 1975 and 
2005, with the largest declines from 1975 through 1979 (Ries et al., 2008).  However, 
survival remains much lower among black women of all ages and across all stages of 
disease (Miller et al., 1993). 
1.1 THE NCI BLACK/WHITE CANCER SURVIVAL STUDY 
The National Cancer Institute conducted a social-epidemiologic study of possible 
behavioral and biologic determinants of black/white racial disparities in cancer survival.   
This study selected four organ sites: cancers of the uterine corpus, breast, bladder, and 
colon (Howard et al., 1992).  Cancer of the uterine corpus was chosen because it showed 
the largest overall racial survival difference (34%). Bladder cancer was selected because 
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the survival difference was greater than 20% for each sex (Myers and Hankey, 1980).  
Female breast cancer was included because it was the leading cause of deaths attributable 
to cancer among women at that time (American Cancer Society, 1982), and the 
black/white difference in survival was greater than 10% after adjustment for age and 
stage (Myers and Hankey, 1980).  Although the data from the SEER Program for the 
diagnostic period 1973 to 1979 indicated a much smaller racial differential (4%) in 
survival from colon cancer (Ries et al., 1983), it was retained since (1) it was the only site 
relevant to both males and females other than bladder cancer; (2) it was the second 
leading cause of deaths attributable to cancer; (3) a significant black/white difference in 
colon cancer survival (17%) was found in the SEER data from Atlanta (Myers and 
Hankey, 1984), which provided an opportunity to evaluate regional disparities in racial 
survival differences; and (4) racial differences in various behavioral and biologic factors 
could be correlated with the size of survival differences found across cancer sites 
(Howard et al., 1992). 
Three population-based cancer registries were selected as data collection centers: 
the Georgia Center for Cancer Statistics, which covered the metropolitan Atlanta area; 
the Louisiana Tumor Registry, which covered the metropolitan New Orleans area; and 
the California Tumor Registry, which covered the metropolitan San Francisco/Oakland 
area.  The absence of a North Central or Northeast area was a recognized limitation of the 
study. 
All black women diagnosed with cancer of the four selected sites during the three 
years period, 1985 to 1987, were included in the study.  Black cases were frequency 
matched to white cases on the basis of age group (< 50, 50-64 and 65 years of age), 
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geographic area Atlanta, New Orleans, or San Francisco/Oakland) and year of diagnosis.  
For breast and colon cancer cases the frequency matching was in the ratio of 1:1, whereas 
for endometrial and bladder cancer, a ratio of 1:2 was chosen to increase the total sample 
size and provide more reliable estimates of the survival ratio comparing blacks to whites.  
Four types of research instruments were used for data collection in this study: an 
abstract of the hospital record, a supplementary abstract of selected items from 
physician’s office records, a pathology review of representative biopsy and surgical 
specimens, and a personal interview with the patient.  
This study involved rapid reporting of patients newly diagnosed with cancer so 
that sampled persons could be interviewed as close to their initial diagnosis as possible. 
Patients were eligible for selection into the study if they met the following criteria: 
1. had invasive or in situ cancer of the uterine corpus, bladder, colon, or female   
breast, excluding lymphomas of these sites; 
2. had no prior cancer except basal or squamous cell carcinoma of the skin; 
3. were either white or black as stated in the hospital record or by the patient; 
4. were 20 to 79 years of age; 
5. were resident at diagnosis in one of the geographic areas included in the study;  
6. had a diagnosis of cancer between January 1, 1985, and December 31, 1986, 
for breast and colon, or through December 31, 1987, for bladder and uterine corpus. 
7. The ability to speak English was added after two years of case accrual. 
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1.2 EXPLANATORY VARIABLES AND HYPOTHESES 
Based on previous studies, potential explanatory variables included in the NCI 
Black/White Cancer Survival Study were factors characterizing stage at diagnosis, 
histopathologic characteristics of the tumor, treatment, concurrent medical conditions, 
health behavior items, hormonal and reproductive history variables, and 
sociodemographic factors. 
The seven hypotheses guiding the design of this study were: 
1. that black patients with cancer might report less pre-diagnostic screening 
activity, less recognition of cancer symptoms, fewer asymptomatic detections, longer 
duration of symptoms, and slower processing within the medical care system than white 
patients; 
 2. that blacks would be under-staged more frequently than whites based largely 
on speculation concerning the quality of medical evaluations for the two races; 
3. that histological characteristics would account for some proportion of the 
black/white survival differences based on biological considerations relating to the cancers 
selected; 
4. that host vulnerability (Dutton, 1979) involving three dimensions might 
contribute to the poorer survival of indigent patients or blacks. The three dimensions 
considered were poorer nutritional status, poorer overall health status, and alcoholism-
related compromise of the immune system; 
5. that black patients with cancer might be prescribed less aggressive treatment 
than white patients with comparable stages of disease; 
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6. that black patients for various reasons might have less adherence to the 
treatment prescribed; and  
7. that social support and coping strategies might affect survival differences by 
facilitating adaptive behavior or compliance with treatment. 
1.3 STUDY SAMPLE AND INCOMPLETENESS  
At the end of 1992 there were 3380 eligible patients with histological or ascertained dates 
of diagnosis during the initial study period of January 1, 1985, through December 31, 
1986 for breast and colon cancer, and January 1, 1985, through December 31, 1987 for 
bladder and endometrial cancer, which contained 649 blacks and 573 whites for breast 
cancer; 493 blacks and 574 whites for colon cancer; 194 blacks and 384 whites for 
bladder cancers; and 168 blacks and 353 whites for endometrial cancer.  These patients 
were followed up from the date they were diagnosed through 2000. 
The major reason for incomplete records in this study is the absence of interviews. 
The overall interview response rate for this study was 77%.  The rates essentially were 
similar for both races, 76% for blacks and 77% for whites, but they varied by data 
collection center, 81% in San Francisco/Oakland, 76% in Atlanta, and 70% in New 
Orleans.  The interview response rate also varied by organ site: 83% for breast, 71% for 
colon, and 75% for uterine corpus and bladder.  The reasons for patient non-response 
were: (1) No attempt was made to contact the patient because physician consent was not 
obtained in 275 cases (8%); (2) When contact was attempted, 6% of the total study 
population had died or were too ill to be interviewed, 8% declined to be interviewed, and 
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2% were non-respondents for other reasons, such as distant residential moves or lost to 
follow-up.  Other reasons for incompleteness are lack of permission to abstract hospital 
records and review microscopic slides and lost to follow-up. 
1.4 PREVIOUS PUBLICATIONS 
There are more than twenty-two published articles based on the NCI Black/White Cancer 
Survival Study, that have identified multiple factors associated with the black/white 
differences in survival for each of the four cancer sites.  Since this thesis focuses on 
analyses of the black/white differences for survival for patients with endometrial cancer, 
we will review here only those papers that have dealt with that cancer site. 
Hill et al. (1995) found over 75% of the excess of poorly differentiated tumors 
versus well-differentiated tumors among blacks could be explained by racial differences 
in use of replacement estrogens, age at first pregnancy, history of oophorectomy, poverty, 
stage of disease, use of screening, and access to health care.  The most prominent factor 
was estrogen therapy, which was associated with favorable tumor grade and was used 
much less frequently by blacks.  Barrett et al. (1995) indicated that high-grade (poorly 
differentiated) lesions increased the risk for stage III or IV disease (odds ratio 8.3, 95% 
confidence interval 3.4 to 20.3), as did serous histological subtype (odds ratio 3.5, 95% 
confidence interval 1.4 to 8.8) and no usual source of care (odds ratio 5.5, 95% 
confidence interval 1.4 to 20.9).  In the final statistical model these three factors also 
accounted for the majority of the excess of advanced stage for blacks.  Coates et al. 
(1996) found that time from symptom recognition to initial medical consultation does not 
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contribute importantly to the more advanced stage of the endometrial cancer commonly 
found among black women, since: (1) median recalled times between symptom 
recognition and consultation were 16 days for black women and 14 days for white 
women; (2) the adjusted consultation rate among black women was only somewhat lower 
(0.87) than among white women, and the 95 percent confidence interval (0.58 to 1.31) 
was consistent with no true difference between the races; (3) the median time to 
consultation for women with stage IV cancer was only 15 days longer than the time (14 
days) for the women with stage I cancer. Hill et al. (1996) found that adjusting for age 
and geographic location, risk of death among black women was 4.0 (95% confidence 
interval [CI] 2.8, 5.6) time that of white women. Approximately 40% of this difference 
could be attributed to a more advanced stage at diagnosis among black women, and 23% 
to tumor characteristics and treatment. Further adjustment for all remaining factors 
reduced the hazard ratio to 1.6 (95% CI 1.0, 2.6).  
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2.0  STATEMENT OF THE PROBLEM 
Endometrial cancer was selected for this analysis because this cancer site had the 
largest overall racial survival difference (34 %).   Other factors involved in the selection 
of endometrial cancer cases for further evaluation were that the interview response rate 
was relatively low (75%) for endometrial cancer, which means that the proportion of 
incomplete data is relatively high for most of the variables.  In addition, there was a 
suggestion of a possible interaction among race, survival, and interview status.  There 
were only four published articles based on the NCI Black/White Cancer Survival Study, 
that investigated the potential explanatory factors for the lower survival rate among black 
women with endometrial cancer when compared to white women: Hill et al. (1995); 
Barrett II et al. (1995); Coates et al. (1996); and Hill et al. (1996).  All four papers 
derived their findings and conclusions based on the incomplete data.  An “unknown” 
category was included for each variable that had at least ten subjects with missing data.  
If fewer than ten subjects were missing, those subjects were excluded from analyses 
using that variable. 
However, there are 13 out of 21 variables having missing data (62%) with a 
missing proportion ranging from 5% to 43% for blacks and 11% to 38% for whites.  
Moreover, it appears that the non-responders have lower survival rates in comparison to 
responders.  Thus, the conclusions derived in the papers might be biased. 
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3.0  STUDY OBJECTIVES 
The main objective of this master’s thesis is to explore the impact of missing data by 
comparing the estimates of the black/white hazard ratio for mortality in Cox regression 
models utilizing the original updated dataset to those based upon imputation of the 
missing data.  The specific aims of the imputation of missing data are to reduce possible 
bias introduced by the use of incomplete data and to achieve more reliable and precise 
findings for potential explanatory factors that account for black/white racial disparities in 
endometrial cancer survival.  A secondary aim is to present analyses that are based on 
additional long-term follow-up that has been completed since the publication of the first 
four papers on black/white differences in endometrial cancer survival. 
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4.0  METHODS 
4.1 DESCRIPTION OF THE ENDOMETRIAL CANCER DATASET 
The updated dataset contains 490 women (149 black, 341 white), who have been 
followed up from the date of diagnosis (1985 -1987) through the year 2000.  Among 
blacks 99 deaths have been observed and among whites 102 deaths have been observed.  
Potential explanatory variables studied for racial differences in survival are design 
variables (age and geographic location), stage at diagnosis based on the International 
Federation of Gynecology and Obstetrics (FIGO) staging system (FIGO, 1988), 
pathologic grade, comorbid conditions, symptoms at diagnosis, patient delay, total delay, 
smoking history, income level, insurance, usual source of care, poverty index, occupation 
class, education, marital status, body mass index quartile, histological subtype, oral 
contraceptive use, menopausal status, and treatment1.  All these variables are categorical.  
Appendix A provides a list of the variables in the dataset along with the categories for 
each variable. 
Table 1 shows the frequency distribution and 5 year survival rates of patients by 
race in each variable.  Chi-square tests were carried out to test the equivalence of survival 
rates for black and white women for each categorical variable individually since the 
majority of the patients had complete follow-up (only 6 censored cases).  The overall 
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five-year survival rate in black women is 0.4748 (95% confidence interval [CI] 0.3944, 
0.5552) and in white women is 0.8138 (95% CI 0.7722, 0.8554).  The chi-square test 
shows a statistically significant overall racial difference in survival (chi-square 72.58, p 
value < .0001).  This significant racial difference in survival also exists in the majority of 
subgroups defined by each variable.  One hundred and nine (73.2%) black and two 
hundred and sixty-two (76.8%) white had been interviewed.  The five-year survival rate 
in non-interviewed blacks is 0.2143 (95% CI 0.0902, 0.3384), and in the blacks 
interviewed the five-year survival is 0.5774 (95% CI 0.4835, 0.6713), which significantly 
differ from each other.  For non-interviewed whites five-year survival is 0.7273 (95% CI 
0.6277, 0.8269), and in interviewed whites it is 0.8392 (95% CI 0.7947, 0.8837), which 
shows the same trend as in blacks. However, there is not a significant difference between 
the interviewed and non-interviewed white women. 
The racial difference in survival is significant in both interviewed and non-
interviewed patients (chi-square 38.29 and 40.47, respectively, p values both < 0.0001). 
The racial difference between survival for interviewed and non-interviewed cancer 
patients is more pronounced for black than for white endometrial cancer patients, 
although a formal test for interaction between interview status and race on survival yields 
a p value of 0.11.  Since many variables were derived from personal interviews, there is 
concern that bias may have been introduced into the multivariable analyses done in 
earlier publications, which were based on the dataset of patients with complete 
information on all variables. 
The difference in stage at diagnosis, which was determined to be the most 
prominent factor in explaining the racial disparity in endometrial cancer survival rates in 
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the paper by Hill et al. (1996), was not derived from personal interviews.  It is interesting 
to evaluate whether the black-to-white hazard ratio differs by interview status within each 
stage since patients with more advanced stage had a lower interview rate.  Table 2 shows 
that the black-to-white hazard ratio is higher in non-interviewed patients compared to 
interviewed patients in stage 1 and 2, but is lower in non-interviewed patients in stage 3 
and 4.  This suggests a 3-way interaction effect among race, stage and interview status.  
4.2 COMPARISON OF RESULTS DERIVED FROM UPDATED DATASET 
FOR ALL CASES AND INTERVIEWED CASES  
Cox proportional hazards models are used to explore the effect of each variable on 
survival time.  The results are somewhat different when the models are built with original 
updated data for all cases and treat unknowns as a separate category compared to only 
interviewed cases, especially for those variables derived from personal interviews.  The 
effects of symptoms, patient delay, total delay, and smoking history on survival are 
significant for cases with complete information, but become non-significant when only 
interviewed cases are analysed.  Table 3 shows the results comparing the estimated 
hazard ratio for mortality between black and white patients for selected Cox proportional 
hazards models.  The hazard ratios estimated based on all cases with complete 
information are a little higher than those estimated based on interviewed cases for each of 
the covariates individually, except when controlling for stage, they are similar to each 
other.  This observation indicates that the racial difference in survival is smaller in 
interviewed women compared to non-interviewed women.  The multivariable analyses, 
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which were based on endometrial cancer cases with complete information, are inefficient 
and subject to bias. 
4.3 IMPUTATION APPROACHES 
4.3.1 Hot-Deck Imputation 
Imputation is a very popular technique for dealing with the missing-data problem.  
It involves filling in the missing values under a certain prediction model and then 
analyzing this imputed dataset as if there were no missing observations.  As one of the 
often-used imputation methods, hot deck imputation is defined as a method where an 
imputed value is selected from an estimated distribution for each missing value.  One 
approach is the nearest neighbor hot deck, which is to define a metric to measure distance 
between units, based on the values of covariates, and then to choose imputed values that 
come from responding units close to the unit with the missing value.  For example, let xi1, 
…, xij be the values of J appropriately scaled covariates for a unit i for which yi  is 
missing.  Define the distance between units i and i’ as 
d (i, i’) = max | xij – xi’j|  
We might choose an imputed value for yi from those unit i’ that are such that (1) 
yi’, xi’1, …, xi’j are observed, and (2) d (i, i’) is less than some value d0. The number of 
candidates i’ can be controlled by varying the value of d0 .(Little and Rubin, 1986) 
In the endometrial cancer dataset the unit is an individual case with its 
corresponding values for the covariates and survival outcome.  The procedure consists of 
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three stages.  First, a computer program is written for the imputation to measure the 
distance between units based on the covariates whose values are known and the survival 
outcome since it is closely related to all the variables that have missing values.  Second, 
the technique identifies the subset of units with known responses that has the smallest 
distance from a unit with a missing value.  Third, a value is randomly drawn from the 
subset of units with known responses to insert in place of the missing value. 
Multiple-imputation is an extension of a single imputation where the imputation 
process described above is repeated n times.  For each of the n independent imputations, 
a “complete” dataset is created in which an imputed value is substituted for each missing 
value.  These n datasets are analyzed separately and the results are combined to form one 
overall inference.  Multiple imputation overcomes one important limitation of single 
imputation, which is that standard variance formulas applied to the imputed values for 
missing data systematically underestimate the variance of estimates, even when the 
model used to generate the imputations is correct. (Little and Rubin, 1986) 
4.3.2 Preparation of endometrial cancer dataset for multiple imputation 
In the NCI Black/White Cancer Survival study, all the variables that need to be imputed 
for the endometrial cancer cases have a significant effect on survival time (Table 3).  
During the first five years of follow-up, information on follow-up for survival is nearly 
complete, with only 6 cases for which follow-up time is censored (cases lost-to-follow-
up) prior to five years (Table 4).  Therefore, survival time can be used for determining the 
distances between units.  First, a categorical variable, which represents survival time, has 
been created, in which the 6 censored survival times are assumed to have survived at least 
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5 years (Table 5).  Among the covariates, there are five variables that have fewer than 
five missing values for either race (table 6). 
Both stage and pathologic grade are highly significantly correlated with survival 
time.  Based an distribution of survival time for cases with known stage at diagnosis, the 
one missing value for stage has been imputed as Stage 1 since its survival time is between 
one and three years (Table 7 & 8).  For the three patients with missing pathologic grades 
the missing value is imputed as Grade 3 for two cases whose survival time was less than 
five years, and Grade 1 for the one patient who survived more than five years (Table 9 & 
10).  Symptoms and patient delay have a direct relationship in that there is no patient 
delay if there are no symptoms at the time of the first hospital visit. Therefore, there is no 
patient delay for the two cases with missing values for symptoms and the missing values 
are imputed as no symptoms.  Menopausal status is closely associated with patient age. 
Therefore, menopausal status has been imputed as premenopausal for patient 20-49 years 
old and postmenopausal for those patients 50-64 years old (Table 11). 
After insertion of values for the five variables above for cases with missing 
information they were treated along with design variables (age and geographic location), 
race and survival time as the variables with complete information used for generating 
imputation code to determine the distance between units for imputing other variables with 
missing values.   
There are three reasons for incompleteness in the data: 1) Lack of permission to 
abstract of hospital records or microscopic slides leads to incomplete records for 
variables derived from medical records, physician records, and pathology review; 2) 
Absence of interview causes variables derived from the interview to be missing; 3) Non-
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response to some of the interview questions make variables derived from the interview 
incomplete even for patients who have interviews.  
1. V1 is defined as variables missing because of lack of access to medical records, 
physician records and pathology review, including comorbidities, BMI and therapy 
(Table 12).  
2. V2 is defined as variables missing only because of absence of interview, 
including smoking history, insurance, education, oral contraceptive use, usual source of 
care and occupation class (Table 13). 
3. V3 is defined as variables missing both because of absence of interview and 
non-response in the interview, including income level, poverty index, total delay and 
patient delay (Table 14). 
Other data preparation tasks included: 1) To avoid sparse data, poverty index 
group 4 (301-400) and 5 (>400) were combined into one group (>300) (Please see 
Appendix A for listing and explanation of variables in the dataset); 2) In order to provide 
a more natural order for occupational class that corresponded with socioeconomic 
variables, the codes for the categories were reassigned as shown in Appendix A. 
4.3.3 Generation of the imputation code-Illustrative example (Poverty Index) 
The poverty index is an explanatory variable of major interest in the study of factors 
related to differential mortality between black and white patients with endometrial 
cancer. In addition, the poverty index, which is computed from the income level and 
household size, is missing for 37% of cases (41% for blacks and 32% for whites).  Not 
only is it missing due to the absence of an interview, but also there are patients 
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interviewed who do not provide information on income, which is needed to calculate the 
index.  During the first stage of the imputation process, we utilize contingency table 
analysis to identify other variables closely associated with the poverty index.  The 
contingency coefficient, which was the measure of association chosen for the analysis, 
was calculated for each cross-classification of the poverty index with other variables.  
The variables were then ranked according to the value of the contingency coefficient of 
their association with poverty index (Table 15).  The second stage of the imputation 
process involved fitting log-linear models to find a subset of multiple variables 
significantly correlated with poverty index (Table 16) from which the missing values of 
the poverty index could then be imputed. 
Race, location, age group and occupational class are four variables highly 
correlated with the poverty index, but they cannot be used to impute all the missing 
values for the poverty index since occupational class is also missing for 119 cases (24%) 
that do not have interviews.  Table 17 shows the distribution of the poverty index by 
occupational class according to whether the data was present or missing.  
At the third stage we used these four variables (race, location, age group and 
occupational class) along with survival time to construct the imputation code for the 51 
(10%) of interviewed cases who were missing information on the poverty index, but who 
had a known occupational class.  The specific code for the imputation was:  
povgpcode= survival time * 10000 + race * 1000 + location * 100 + occupation 
class * 10+ age group * 1 
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For the 119 (24%) of cases that did not have interview data, race, location, age 
group and survival time was used in the imputation code, since occupational class was 
not available.  The code for this imputation was: 
povgpcode2= Survival time*1000+Race*100+Location*10+Age group*1 
Analogous procedures were carried out to impute values for other variables with 
missing data. (Appendix B). 
4.3.4 Multiple imputation 
Multiple imputations were carried out to overcome an obvious disadvantage of single 
imputation, that it cannot reflect sampling variability under one model for non-response 
or uncertainty about the correct model for non-response.  With multiple imputations, the 
resulting n complete-data analyses can be easily combined to create an inference that 
valid reflects sampling variability because of the missing value, and uncertainty about the 
correct model was displayed by the variation in valid inferences across the models since 
more than one model was used.  
R (a programming language and software environment for statistical computing 
and graphics) was used to carry out the nearest neighbor hot deck imputation process.  
First, a subset of subjects with complete information, who have the closest distance to the 
case with a missing value was identified by comparing the difference in imputation code 
between the cases with complete information with the case whose information was 
missing.  Then a value was drawn at random from the subset of cases with known values 
to replace the missing values.  This procedure was repeated 50 times to get 50 new 
“complete” datasets.  The code for this stage is provided in Appendix C. 
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The Cox regression analysis for each of the 50 imputed datasets was carried out in 
order to obtain more reliable estimates and the variability associated with the imputation 
of the missing values.  The eight steps in the multiple imputation are: 
1. Build the models with selected covariates in each of the 50 imputed datasets. 
2. Calculate the estimated coefficients (Qd, d=1,…,50) and standard errors (Wd,   
     d=1,…,50) for race in the Cox proportional hazards models. 
3. Estimate the combined coefficient for race in each model by  
; 
4. Estimate the combined black to white hazard ratio in each model by 
);exp( 50θ=raceHR  
5. Estimate the average within-imputation variance by 
; 
6. Estimate the  between-imputation variance by 
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7. Estimate the total variability associated with the imputation of the missing 
values by 
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8. At the final step estimate the fraction of information about the black to white 
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5.0  RESULTS 
5.1 DISTRIBUTION OF IMPUTED DATA COMPARED TO ORIGINAL 
DATA- ILLUSTRATIVE EXAMPLE FOR THE POVERTY INDEX 
In order to verify that the imputation has been carried out appropriately, the properties of 
the dataset from one of the imputations is examined.  As would be expected, there has 
been no obvious change in the frequency distributions (Table 18, Figure 1 and Figure 2) 
or hazard ratios for mortality (Table 19) when the original updated data on the poverty 
index are compared to the imputed dataset.  Similar comparisons of other variables in 
original and imputed datasets are provided in Appendix D. 
5.2 MULTIVARIABLE COX REGRESSION MODELS OF THE 
BLACK/WHITE HAZARD RATIOS ADJUSTING FOR SELECTED 
COVARIATES BASED ON THE ORIGINAL DATASET 
The second line for each Cox regression model with selected variables in Table 20 shows 
the estimates of hazard ratios for mortality among black women compared to white 
women with endometrial cancer after controlling for selected covariates utilizing the 
original updated dataset.  Adjustment for sociodemographic factors (marital status, 
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poverty index, occupation, usual source of care, insurance, education) has a dramatic 
impact on the racial difference in survival from endometrial cancer, while hormonal and 
reproductive factors (menopausal status, use of oral contraceptives) and treatment have a 
relatively small effect.  Stage, tumor characteristics (pathologic grade, histological tumor 
subtype), comorbidities and health behavior (number of comorbid conditions, body mass 
index (BMI), smoking history, total delay, patient delay) have a moderate influence on 
the racial survival differences.   After multivariable adjustment for all covariates, the 
racial hazards ratio becomes 1.3 (95% confidence interval 0.7, 2.6). 
When we use a stepwise procedure, setting the p value for entering at 0.20, and 
the p value for removing a covariate at 0.10 in order to select covariates for the full 
model, stage, poverty index, histology, treatment, type of insurance, patient delay, 
occupational class, BMI, usual source of care, and total delay would be included.  The 
hazards ratio for mortality among black women compared to white women estimated in 
this full model is 1.8 with a 95% confidence interval of 1.0 to 3.1.  Therefore, stage, 
poverty index, histology, treatment, type of insurance, patient delay, occupational class, 
BMI, usual source of care, and total delay explain 77% of the reduction in the black to 
white hazard ratio for mortality by including all covariates. 
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5.3 MULTIVARIABLE COX REGRESSION MODELS OF THE 
BLACK/WHITE HAZARD RATIOS ADJUSTING FOR SELECTED 
COVARIATES BASED ON THE MULTIPLE IMPUTED DATASETS 
The third line for each Cox regression model with selected variables in Table 20 shows 
the combined estimates of hazard ratios for mortality among black women compared to 
white women after controlling for selected covariates utilizing the 50 imputed datasets. 
Sociodemographic factors (marital status, poverty index, occupation, usual source of 
care, type of insurance, education) still had a dramatic impact on the racial difference in 
survival from endometrial cancer.  The hormonal and reproductive factors (menopausal 
status, use of oral contraceptives) have the smallest effect.  In multivariable adjustment 
for all covariates, the hazard ratio of black women compared to white women is 1.2, 
which is a little less than the hazard ratio estimated from the original data.  In addition, 
the 95% confidence intervals for all the estimated hazards ratios are narrower than those 
estimated with the original data. 
The estimate of average within-imputation variance is 0.048, the between-
imputation variance is 0.0049, and the total variability associated with the imputation of 
the missing values is 0.053.  Overall, 9.4% of the information of explanatory variables 
related to the black/white hazard ratio is missing.  
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6.0  DISCUSSION 
The previous analyses by Hill (1996) showed that the risk of death among black women 
was 4.0 times greater (95% confidence interval [CI] 2.8, 5.6) than that of white women 
when only the design variables (age and geographic location) are taken into account. 
Approximately 40% of this difference could be attributed to a more advanced stage at 
diagnosis among black women, and 23% to tumor characteristics and treatment. 
Adjustment for all remaining factors reduced the hazard ratio further to 1.6 (95% CI 1.0, 
2.6). 
With the updated follow-up data the black/white hazard ratio for mortality was 
3.3 after adjustment for age and geographic location and 1.3 after adjustment for all 
covariates. Although the hazard ratio for mortality decreased somewhat with long-term 
follow-up, it is still substantially elevated.  As in the prior analyses, the most important 
factor related to black/white differences was stage of disease at diagnosis.  More 
advanced stage at diagnosis among black women explained 35% of the excess mortality 
among black women.  The reason for the somewhat lower overall black/white hazard 
ratio for mortality in the present analyses (3.3 versus 4.0) may be that with longer 
observation time, there is a tendency for the early marked differences to become 
attenuated.  In other words the observed black/white survival difference is less 
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pronounced in additional follow-up among those women who survived longer compared 
to those who died within the first few years following diagnosis. 
The combined estimates of hazard ratios of mortality for race from Cox 
multivariable proportional hazard models with selected covariates derived from the 50 
imputed datasets are very similar to those estimated with the original updated dataset. 
Therefore, it appears that missing data did not introduce substantial bias into the analyses 
based on the original updated dataset, even though the fraction of missing data was as 
high as 9 to 10 percent for some of the covariates of interest. However, the 95% 
confidence intervals are much narrower with imputed data, which indicates that the 
imputation of the missing data increases the precision of the estimates.  
Our analyses based on imputing missing observations continues to provide 
evidence that sociodemographic factors (marital status, poverty index, occupation, usual 
source of care, insurance, education) are the most important variables in explaining the 
disparity in endometrial cancer survival rates between black and white women.  Taken 
together, they explain 65% of the excess mortality among black women after adjustment 
for age and geographical location (adjusted hazard ratio 1.8 versus unadjusted hazard 
ratio 3.3). Comorbidities and health behavior factors (comorbidity, BMI, smoking 
history, total delay, patient delay) also contribute substantially to the excess mortality 
(adjusted hazard ratio 2.5 versus unadjusted hazard ratio 3.3).  Hormonal and 
reproductive factors (menopausal status, use of oral contraceptives) only explain a 
relative small proportion of the racial disparities in survival (adjusted hazard ratio 3.1 
versus unadjusted hazard ratio 3.3).  The lack of importance of menopausal status in the 
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model may be related to its collinearity with age, which is included in all models since 
black women were frequency matched to white women by age.  
There are several potential limitations to the current analysis:  
All underlying prognostic factors may not have been included in the study.  A 
potential prognostic variable absent in this analysis is peritoneal cytology. 
Misclassification may have occurred in some of the covariates, such as those from 
the interview, which relate to sensitive information, such as income.  Misclassification 
could also be present if black women are under-staged because they receive fewer staging 
tests than whites. 
The imputation process may also have introduced some bias.  When generating 
the imputation code for each variable, race was generally closely associated with the 
covariate of interest.  Therefore, the imputations are always performed within a racial 
group.  
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7.0  CONCLUSION 
Missing data did not introduce significant bias in the earlier papers since the estimates of 
the hazard ratio for mortality based on fifty imputed datasets were similar to those based 
on the updated original dataset.  However, the multiple imputation provided estimates of 
confidence intervals that were narrower than those previously published.  The multiple 
imputation was, therefore, worthwhile since it gave more precise estimates for the 
relative survival ratios. The most important explanatory variables for a lower survival 
rate among black women with endometrial cancer when compared to white women are 
sociodemographic factors (marital status, poverty index, occupation, usual source of care, 
insurance, education), stage at diagnosis, and comorbidities and health behavior factors 
(comorbidity, BMI, smoking history, total delay, patient delay).   Overall, 87% of the 
excess mortality could be attributed to racial differences in stage at diagnosis, tumor 
characteristics, treatment, sociodemographic characteristics, hormonal and reproductive 
factors and factors related to number of comorbidities and health behavior. 
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8.0  TABLES AND FIGURES 
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Table 1: Five­year survival and its 95% confidence interval (CI) by race for each of the 
covariates 
Study 
Variable Category Black White 
Chi-
square 
test 
  N Deaths 5 year survival 
95% CI 
 N Deaths 
5 year 
survival 
95% CI 
 p-value*
Race  149 99 0.47 (0.39, 0.56) 341 102 0.81 (0.77, 0.86) <.0001 
Location+           
 Atlanta 47 29 0.49 (0.34, 0.63) 96 26 0.85 (0.78, 0.92) <.0001 
 New Orleans 52 40 0.42 (0.29, 0.56) 90 29 0.79 (0.70, 0.87) <.0001 
 San Fran/Oak** 50 30 0.52 (0.38, 0.66) 155 47 0.80 (0.74, 0.87) <.0001 
Age Group+           
 20-49 17 7 0.82 (0.64, 1.00) 44 4 0.90 (0.81, 0.99) 0.0037 
 50-64 53 27 0.62 (0.49, 0.75) 120 27 0.87 (0.81, 0.93) 0.0001 
 65-79 79 65 0.30 (0.20, 0.41) 177 71 0.76 (0.69, 0.82) <.0001 
Stage           
 Unknown 1 1 0.00 (0.00, 0.00) 0 0    
 1 96 52 0.66 (0.57, 0.76) 283 67 0.89 (0.85, 0.92) <.0001 
 2 14 12 0.21 (0.00, 0.43) 23 8 0.74 (0.56, 0.92) 0.0011 
 3 18 15 0.17 (0.00, 0.34) 25 17 0.38 (0.18, 0.57) 0.17 
 4 20 19 0.05 (0.00, 0.15) 10 10 0.00 (0.00, 0.00) 0.61 
Interviewed           
 No 40 35 0.21 (0.09, 0.34) 79 34 0.73 (0.63, 0.83) <.0001 
 Yes 109 64 0.58 (0.48, 0.67) 262 68 0.84 (0.79, 0.88) <.0001 
Grade           
 Unknown 2 2 0.00 (0.00, 0.00) 1 0 1.00 (1.00, 1.00) 0.23 
 1 51 22 0.70 (0.58, 0.83) 176 38 0.89 (0.85, 0.94) 0.0009 
 2 51 38 0.45 (0.31, 0.59) 110 36 0.81 (0.74, 0.89) <.0001 
 3 45 37 0.27 (0.14, 0.40) 54 28 0.56 (0.42, 0.69) 0.0011 
Comorbidity           
 Unknown 8 3 0.75 (0.45, 1.05) 37 9 0.84 (0.72, 0.96) 0.41 
 No 21 12 0.57 (0.36, 0.78) 105 20 0.89 (0.83, 0.95) <.0001 
 Yes 120 84 0.44 (0.35, 0.53) 199 73 0.77 (0.71, 0.83) <.0001 
+ Design variables 
* P value from chi-square test for the null hypothesis that the five-year survival rates are the same between black and white women in 
ch of the category ea
** San Francisco-Oakland 
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Table 1: Five­year survival and its 95% confidence interval (CI) by race for each of the 
covariates (continued) 
Study 
Variable Category Black White 
Chi-
square 
test 
  N Deaths 5 year survival 
95% CI 
 N Deaths 
5 year 
survival 
95% CI 
 p-value*
Symptoms           
 Unknown . . .  2 2 0.50 (0.00, 1.19) . 
 No 3 2 0.33 (0.00, 0.87) 20 3 0.95 (0.85, 1.05) 0.018 
 Yes 146 97 0.48 (0.40, 0.56) 319 97 0.81 (0.76, 0.85) <.0001 
Patient Delay           
 Unknown 46 39 0.26 (0.13, 0.39) 86 35 0.74 (0.65, 0.84) <.0001 
 No 3 2 0.33 (0.00, 0.87) 22 5 0.91 (0.79, 1.03) 0.066 
 0-<1m** 59 34 0.56 (0.43, 0.69) 155 46 0.82 (0.76, 0.88) <.0001 
 1-<3m** 15 8 0.60 (0.35, 0.85) 33 8 0.82 (0.69, 0.95) 0.035 
 3-<6m** 10 5 0.70 (0.42, 0.98) 19 3 0.84 (0.67, 1.01) 0.12 
 >=6m** 16 11 0.56 (0.31, 0.80) 26 5 0.92 (0.82, 1.03) 0.0002 
Total Delay           
 Unknown 50 42 0.26 (0.14, 0.38) 94 39 0.74 (0.66, 0.83) <.0001 
 0-<1m** 39 20 0.64 (0.49, 0.79) 89 30 0.81 (0.73, 0.89) 0.066 
 1-<3m** 22 19 0.32 (0.12, 0.51) 55 14 0.85 (0.76, 0.95) <.0001 
 3-<6m** 14 6 0.64 (0.39, 0.89) 38 7 0.84 (0.72, 0.96) 0.074 
 >=6m** 24 12 0.71 (0.52, 0.89) 65 12 0.88 (0.80, 0.96) 0.0017 
Smoking 
History           
 Unknown 42 36 0.21 (0.09, 0.34) 77 35 0.73 (0.63, 0.83) <.0001 
 Never 71 41 0.52 (0.40, 0.63) 145 38 0.85 (0.79, 0.91) <.0001 
 Former 25 16 0.64 (0.45, 0.83) 89 23 0.82 (0.74, 0.90) 0.0006 
 Current 11 6 0.82 (0.59, 1.05) 30 6 0.86 (0.74, 0.99) 0.064  
Income           
 <10K 60 41 0.49 (0.37, 0.62) 52 16 0.76 (0.64, 0.88) 0.0003 
 10-<20K 19 9 0.68 (0.48, 0.89) 55 18 0.78 (0.67, 0.89) 0.24 
 20-<35K 5 1 1.00 (1.00, 1.00) 64 13 0.89 (0.81, 0.97) 0.91 
 35K 4 1 0.75 (0.33, 1.17) 64 8 0.95 (0.90, 1.00) 0.36 
 Unknown 61 47 0.33 (0.21, 0.45) 106 47 0.73 (0.64, 0.81) <.0001 
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** Month 
* P value from chi‐square test for the null hypothesis that the five‐year survival rates are the same between black and white 
women in each of the category 
Table 1: Five­year survival and its 95% confidence interval (CI) by race for each of the 
covariates (continued) 
Study 
Variable Category Black White 
Chi-
square 
test 
  N Deaths 5 year survival 
95% CI 
 N Deaths 
5 year 
survival 
95% CI 
 p-value*
Insurance           
 None 15 7 0.73 (0.51, 0.96) 12 5 0.67 (0.40, 0.93) 0.98 
 Public 42 34 0.38 (0.23, 0.53) 25 7 0.83 (0.68, 0.98) <.0001 
 Any 50 22 0.70 (0.57, 0.83) 227 55 0.85 (0.80, 0.90) 0.0023 
 Unknown 42 36 0.21 (0.09, 0.34) 77 35 0.73 (0.63, 0.83) <.0001 
Usual Source 
of Care           
 None 14 11 0.36 (0.11, 0.61) 27 5 0.84 (0.70, 0.98) <.0001 
 Public 32 21 0.63 (0.46, 0.79) 7 1 0.86 (0.60, 1.12) 0.047 
 Private 61 31 0.60 (0.48, 0.73) 229 61 0.84 (0.79, 0.89) <.0001 
 Unknown 42 36 0.21 (0.09, 0.34) 78 35 0.73 (0.63, 0.83) <.0001 
Poverty Index           
 0-125 58 40 0.49 (0.37, 0.62) 46 14 0.75 (0.62, 0.88) 0.0006 
 126-200 11 7 0.55 (0.25, 0.84) 22 5 0.86 (0.72, 1.01) 0.021 
 201-300 12 4 0.83 (0.62, 1.04) 32 15 0.69 (0.53, 0.85) 0.40 
 301-400 1 0 1.00 (1.00, 1.00) 32 6 0.88 (0.76, 0.99) 0.64 
 >400 6 1 0.83 (0.54, 1.13) 100 15 0.94 (0.89, 0.99) 0.85 
 Unknown 61 47 0.33 (0.21, 0.45) 109 47 0.73 (0.65, 0.82) <.0001 
Occupation 
Class           
 Unknown 43 37 0.23 (0.11, 0.36) 79 36 0.73 (0.64, 0.83) <.0001 
 Home-maker 15 8 0.60 (0.35, 0.85) 36 11 0.78 (0.64, 0.91) 0.21 
 Mgt/Prof ** 12 6 0.58 (0.30, 0.86) 75 16 0.85 (0.77, 0.93) 0.011 
 Tech/Sales+ 12 4 0.75 (0.51, 1.00) 97 19 0.91 (0.85, 0.96) 0.27 
 Skilled 37 20 0.62 (0.46, 0.77) 38 13 0.75 (0.61, 0.89) 0.13 
 Unskilled 30 24 0.43 (0.26, 0.61) 16 7 0.69 (0.46, 0.91) 0.032 
** Management or professional worker 
+ Technique or sales  
* P value from chi‐square test for the null hypothesis that the five‐year survival rates are the same between black and white 
women in each of the category 
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Table 1: Five­year survival and its 95% confidence interval (CI) by race for each of the 
covariates (continued) 
Study 
Variable Category Black White 
Chi-
square 
test 
  N Deaths 5 year survival 
95% CI 
 N Deaths 
5 year 
survival 
95% CI 
 p-value*
Education           
 Unknown 42 36 0.21 (0.09, 0.34) 77 35 0.73 (0.63, 0.83) <.0001 
 < High school 59 39 0.52 (0.39, 0.65) 51 18 0.76 (0.65, 0.88) 0.0022 
 High School Grad 29 14 0.69 (0.52, 0.86) 92 24 0.82 (0.74, 0.89) 0.030 
 > High school 19 10 0.58 (0.36, 0.80) 121 25 0.89 (0.83, 0.95) 0.0004 
Marital Status           
 Unknown 6 4 0.33 (0.00, 0.71) 2 0 1.00 (1.00, 1.00) 0.17 
 Partnered 48 29 0.56 (0.42, 0.70) 181 43 0.86 (0.81, 0.91) <.0001 
 Widowed 63 45 0.41 (0.29, 0.53) 93 40 0.71 (0.62, 0.80) 0.0005 
 Div/Sep** 26 19 0.46 (0.27, 0.65) 41 8 0.87 (0.77, 0.98) <.0001 
 Never married 6 2 0.67 (0.29, 1.04) 24 11 0.74 (0.56, 0.92) 0.77 
Body Mass 
Index 
Quartile 
(BMI) 
          
 Unknown 32 28 0.19 (0.05, 0.32) 44 22 0.73 (0.60, 0.86) <.0001 
 Low normal 7 4 0.71 (0.38, 1.05) 99 22 0.90 (0.84, 0.96) 0.042 
 High normal 11 5 0.64 (0.35, 0.92) 69 22 0.77 (0.67, 0.87) 0.33 
 Overweight 30 19 0.42 (0.24, 0.60) 66 14 0.89 (0.82, 0.97) <.0001 
 Very overweight 69 43 0.58 (0.46, 0.70) 63 22 0.71 (0.60, 0.83) 0.0055 
Histology           
 Others 45 35 0.32 (0.19, 0.46) 33 19 0.56 (0.39, 0.74) 0.058 
 Adenosqua-mous 104 64 0.54 (0.44, 0.63) 308 83 0.84 (0.80, 0.88) <.0001 
 
** Divorced or separated 
 * P value from chi-square test for the null hypothesis that the five-year survival rates are the same between black and white women in 
each of the category 
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Table 1: Five­year survival and its 95% confidence interval (CI) by race for each of the 
covariates (continued) 
Study 
Variable Category Black White 
Chi-
square 
test 
  N Deaths 5 year survival 
95% CI 
 N Deaths 
5 year 
survival 
95% CI 
 p-value*
Treatment+            
 Surgery Only 42 18 0.74 (0.60, 0.87) 148 28 0.89 (0.84, 0.94) 0.0009 
 No Surgery 39 36 0.15 (0.04, 0.27) 16 9 0.63 (0.39, 0.86) 0.0022 
 Surg. Plus Chemo++ 11 8 0.36 (0.08, 0.65) 12 9 0.33 (0.07, 0.60) 0.71 
 Surg. Plus Hormn+++ 6 5 0.17 (0.00, 0.46) 7 6 0.43 (0.06, 0.80) 0.87 
 Surg Plus CandH++++ 1 1 0.00 (0.00, 0.00) 5 5 0.20 (0.00, 0.55) 0.65 
 Surg Plus RT** 48 31 0.50 (0.36, 0.64) 124 46 0.80 (0.73, 0.87) 0.0003 
 Surg+ RT+ CT/HT*** 16 12 0.31 (0.09, 0.54) 14 10 0.43 (0.17, 0.69) 0.0003 
 Unknown 64 48 0.41 (0.29, 0.53) 129 49 0.77 (0.69, 0.84) <.0001 
Oral 
Contracep-
tive Use 
          
 No interview 46 36 0.21 (0.09, 0.34) 77 35 0.73 (0.63, 0.83) <.0001 
 Not used 94 60 0.53 (0.43, 0.63) 197 59 0.81 (0.44, 1.18) <.0001 
 Used 13 3 0.92 (0.78, 1.07) 67 8 0.92 (0.86, 0.99) 0.29 
           
Menopausal 
status           
 Unknown 3 2 0.33 (0.00, 0.87) 3 0 1.00 (1.00, 1.00) 0.12 
 Pre-menopausal 20 7 0.90 (0.77, 1.03) 59 6 0.93 (0.86, 1.00) 0.0096 
 Post-menopausal 126 90 0.41 (0.33, 0.50) 279 96 0.79 (0.74, 0.84) <.0001 
＋Not mutually exclusive 
++ Surgery plus chemotherapy; +++Surgery plus hormonotherapy; ++++ Surgery plus chemotherapy and hormonotherapy 
**Surgery plus radiotherapy; *** Surgery plus radiotherapy and either chemotherapy or hormonotherapy 
* P value from chi-square test for the null hypothesis that the five-year survival rates are the same between black and white women in 
each of the category 
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Table 2: Black to white hazard ratio for overall mortality and its 95% confidence interval (CI) 
by interview status and FICO stage 
Stage Interviewed 
N 
HR 95% CI 
White Black 
1 No 67 23 4.01 (2.02, 7.98) 
 Yes 216 73 3.03 (1.89, 4.86) 
2 No 4 3 -* -* 
 Yes 19 11 4.70 (1.37, 16.13) 
3 No 3 4 1.62 (0.14, 18.31) 
 Yes 22 14 2.34 (0.78, 7.03) 
4 No 3 12 0.00 -* 
 Yes 7 8 1.66 (0.43, 6.39) 
           ＊ Can not estimate because of inadequate sample size 
 
Table 3: Black to white hazard ratio for overall mortality and its 95% confidence interval (CI) 
in selected Cox proportional hazards models 
 
In the dataset based on all cases  
(treat unknowns as  
a separate category) 
 
In the dataset based on cases interviewed 
 
 
Variable other 
than race in the 
model: 
Hazard 
Ratio 95% CI 
Hazard 
Ratio 95% CI 
None 3.27 (2.46, 4.34) 3.00 (2.11, 4.27) 
Stage 2.52 (1.86, 3.40) 2.65 (1.84, 3.82) 
Grade 2.83 (2.12, 3.77) 2.63 (1.85, 3.76) 
Comorbidity 2.99 (2.24, 4.00) 2.80 (1.96, 4.00) 
Symptoms 3.27 (2.46, 4.35) 2.97 (2.08, 4.23) 
Patient Delay 3.45 (2.58, 4.60) 2.99 (2.09, 4.27) 
Total Delay 3.48 (2.61, 4.63) 3.07 (2.15, 4.37) 
Smoking history 3.54 (2.66, 4.72) 2.99 (2.10, 4.26) 
Income 2.92 (2.15, 3.97) 2.36 (1.61, 3.48) 
Insurance 3.28 (2.41, 4.47) 2.59 (1.75, 3.84) 
Usual Source of 
Care 3.55 (2.63, 4.79) 2.94 (2.01, 4.28) 
Poverty Index 2.84 (2.09, 3.86) 2.25 (1.53, 3.32) 
Occupation 
Class 3.09 (2.26, 4.22) 2.30 (1.54, 3.43) 
Education 3.36 (2.48, 4.56) 2.70 (1.84, 3.96) 
Marital Status 3.08 (2.30, 4.13) 2.76 (1.92, 3.96) 
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Table 4: Censoring status by survival time 
Censoring Survival time 
Status ≤1 year 1<years≤3 3<years≤5 >5 years 
Yes 2(3.33%) 3(5.56%) 1(3.03%) 283(82.51%) 
No 58(96.67%) 51(94.44%) 32(96.97%) 60(17.49%) 
 
Table 5: Define categorical survival time 
Original Survival 
Time (years) Survival Time Category 
≤1 year 1 
1<years≤3 2 
3<years≤5 3 
>5 years* 4 
* assume those censored patients will survival greater than 5 years 
 
Table 6: Complete covariates used to generate imputation code 
Variable name Black White 
 Total Missing # Total Missing # 
Stage 149 1 341 0 
Pathologic Grade 149 2 341 1 
Symptoms 149 0 341 2 
Histology 149 0 341 0 
Menopausal status 149 3 341 3 
 
Table 7: Distribution of stage by survival time 
Stage Survival Time (years) 
 ≤1 years 1<years≤3 3<years≤5 >5 years* Total 
1 22 26 21 310 379 
2 7 5 5 20 37 
3 9 17 5 12 43 
4 22 5 2 1 30 
Total 60 53 33 343 489 
* assume those censored patients will survival greater than 5 years 
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Table 8: Distribution of missing in stage by survival time 
Stage missing Survival Time (years) 
≤1 year 1<years≤3 3<years≤5 >5 years* Total 
No 60 53 33 343 489 
Yes 0 1 0 0 1 
 60 54 33 343 490 
* assume those censored patients will survival greater than 5 years 
 
 
Table 9: Distribution of grade by survival time 
* assume those censored patients will survival greater than 5 years 
Grade Survival Time (years) 
 ≤1 year 1<years≤3 3<years≤5 >5 years* Total 
1 10 16 10 191 227 
2 20 23 9 109 161 
3 29 15 13 42 99 
Total 59 54 32 342 487 
 
Table 10 : Distribution of missing grade by survival time 
Grade 
Missing 
Survival Time (years) 
≤1 year 1<years≤3 3<years≤5 >5 years* Total 
No 59 54 32 342 487 
Yes 1 0 1 1 3 
Total 60 54 33 343 490 
* assume those censored patients will survival greater than 5 years 
 
Table 11: Distribution of menopausal status by age group 
Menopausal 
status Age group 
 20-49 50-64 65-79 Total 
Premenopausal 59 169 256 484 
Postmenopausal 2 4 0 6 
Total 61 173 256 490 
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 Table 12 : Variables that are derived from medical records, physician records, and pathology 
review 
 Black (n=149) 
White 
(n=341) 
Variable name # Missing # Missing 
Comorbidity 8 37 
BMI 32 44 
Therapy 64 129 
 
 
Table 13: Variables missing only because of non­interview 
 Black (n=149) White (n=341) 
Variable name # Non-interviewed   # Missing  
# Non-
interviewed  # Missing  
Smoking History 42 42 77 77 
Insurance 42 42 77 77 
Education 42 42 77 77 
Oral Contraceptive 
Use 42 42 77 77 
Usual Source of Care 42 42 77 78 
Occupation Class 42 43 77 79 
 
Table 14: Variables missing because of non­interview and non­response in the interview 
 Black (n=149) White (n=341) 
Variable name # Non-interviewed  # Missing 
# Non-
interviewed  # Missing 
Income 42 61 77 106 
Poverty Index 42 61 77 109 
Total Delay 42 50 77 94 
Patient Delay 42 46 77 86 
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Table 15: Associations between specified variables and poverty index for cases with complete 
information 
Complete  Contingency Coefficient** 
Rank of association with 
Poverty index 
Variables Race 0.44 1 
 Stage 0.25 4 
 Location 0.32 2 
 Age group 0.24 5 
 Grade 0.25 3 
 Symptoms 0.05 8 
 Histology 0.22 6 
 Menopausal status 0.19 7 
    
V2* Smoking history 0.15 6 
 Type of insurance 0.50 2 
 Education 0.50 3 
 Oral contraceptive use 0.26 5 
 Usual source of care 0.35 4 
 Occupation Class 0.54 1 
＊ Variables missing only because absence of interview 
＊＊A measurement of association for contingency tables (Cohen, 1960) 
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Table 16: Log­linear models for subset of variables correlated with poverty index 
  Chi-Square Df P-value 
Complete Race 55.31 3 <.0001 
Variables Location | Race 28.73 6 <.0001 
 Grade | Race, Location 10.05 6 0.12 
 Stage | Race, Location 9.99 8 0.27 
 Age group | Race, Location 12.82 6 0.046 
 Histology | Race, Location, Age group 2.02 3 0.57 
 Menopausal status | Race, Location, Age group 0.47 2 0.79 
 Symptoms | Race, Location, Age group 0   
     
V2*     
 Occupation Class| Race, Location, Age group 26.78 11 0.005 
 Insurance| Race, Location, Age group, Occupation class 2.53 6 0.87 
 Education | Race, Location, Age group, Occupation class 3.53 6 0.74 
 Usual Source of Care | Race, Location, Age group, Occupation class 2.35 6 0.88 
 Oral Contraceptive use| Race, Location, Age group, Occupation class 1.41 3 0.70 
 Smoking history | Race, Location, Age group, Occupation class 3.39 6 0.76 
＊Variables missing only because absence of interview 
 
Table 17: The cross classification of the poverty index by occupational class according to 
whether information is present or missing 
Poverty index Occupation class  
 Present Missing Total 
Present 317(65%) 3(1%) 320(65%) 
Missing 51(10%) 119 (24%) 170(35%) 
Total 368(75%) 12(25%) 490(100%) 
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 Table 18 : The frequency distribution of poverty index in original data and imputed data 
 
 
Original 
 
 
 
Imputed 
 
 
 Total (N=320) 
White 
(N= 232) 
Black 
(N=88)  
Total 
(N=490) 
White 
(N=341) 
Black 
(N=149) 
Poverty 
index 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
Poverty 
index 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
0-125 32.5 19.83 65.91 0-125 37.35 23.75 68.46 
126-200 10.31 9.48 12.50 126-200 10.41 10.26 10.74 
201-300 13.75 13.79 13.64 201-300 14.29 14.08 14.77 
>300 43.44 56.90 7.95 >300 37.96 51.91 6.04 
 
Table 19: Hazard ratio (HR) for overall mortality and its 95% confidence interval (CI) for 
poverty index in original data and imputed data 
 
Original 
 
 
Imputed 
 
 
Poverty 
index HR 95% CI HR 95% CI 
0-125* 2.41 (1.33, 4.39) 3.79 (2.38, 6.04) 
126-200* 1.57 (0.75, 3.29) 2.04 (1.15, 3.63) 
201-300* 2.28 (1.20, 4.34) 2.86 (1.73, 4.74) 
* Reference group is the group with poverty index greater than 300 
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Table 20: Comparison of estimated hazard ratios for overall mortality from the paper by Hill 
et al (1996) with those based on the updated original dataset and the multiply imputed 
dataset adjusting for selected covariates using Cox proportional hazards models  
* Source:  Hill HA et al (1996)  ** All the models include age and location. 
Variables in the Model** 
 
 
 
Covariate: Source Hazard Ratio for Race 95% Confidence Interval 
Race (only) 
Table 4, Hill et al 
(1996)* 4.0 (2.8, 5.6) 
Updated original 
dataset 3.3 (2.5, 4.3) 
Multiply imputed 
dataset 3.3 (2.5, 4.3) 
Stage 
Table 4, Hill et al 
(1996)* 2.8 (1.9, 4.0) 
Updated original 
dataset 2.5 (1.9, 3.4) 
Multiply imputed 
dataset 2.5 (1.9, 3.4) 
Tumor characteristics 
Table 4, Hill et al 
(1996)* 3.1 (2.2, 4.4) 
Updated original 
dataset 2.6 (2.0, 3.5) 
Multiply imputed 
dataset 2.6 (2.0, 3.5) 
Treatment 
Table 4, Hill et al 
(1996)* 3.1 (2.1, 4.5) 
Updated original 
dataset 3.0 (2.0, 3.7) 
Multiply imputed 
dataset 2.8 (2.1, 3.6) 
Sociodemographic 
Table 4, Hill et al 
(1996)* 3.3 (2.2, 4.9) 
Updated original 
dataset 1.8 (1.1, 3.0) 
Multiply imputed 
dataset 1.8 (1.4, 2.7) 
Hormonal and reproductive 
Table 4, Hill et al 
(1996)* 3.4 (2.3, 5.0) 
Updated original 
dataset 3.0 (2.0, 4.1) 
Multiply imputed 
dataset 3.1 (2.4, 4.1) 
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Table 20: Comparison of estimated hazard ratios for overall mortality from the paper by Hill 
et al (1996) with those based on the updated original dataset and the multiply imputed 
dataset adjusting for selected covariates using Cox proportional hazards models (continued) 
* Source:  Hill HA et al (1996) ** All the models include age and location. 
Comorbidities and health behavior 
Table 4, Hill et al 
(1996)* 3.3 (2.3, 4.9) 
Updated original 
dataset 2.6 (1.6, 4.0) 
Multiply imputed 
dataset 2.5 (2.0, 3.7) 
Stage, tumor characteristics 
Table 4, Hill et al 
(1996)* 2.5 (1.7, 3.6) 
Updated original 
dataset 2.3 (1.7, 3.1) 
Multiply imputed 
dataset 2.3 (1.7, 3.1) 
Stage, tumor characteristics, 
treatment 
Table 4, Hill et al 
(1996)* 2.1 (1.4, 3.2) 
Updated original 
dataset 2.2 (1.5, 3.0) 
Multiply imputed 
dataset 2.1 (1.5, 2.8) 
Stage, tumor characteristics, 
treatment, hormonal and 
reproductive 
Table 4, Hill et al 
(1996)* 1.9 (1.2, 3.0) 
Updated original 
dataset 2.3 (1.5, 3.4) 
Multiply imputed 
dataset 2.1 (1.5, 2.8) 
Stage, tumor characteristics, 
treatment, hormonal and 
reproductive, comorbidities and 
health behavior 
Table 4, Hill et al 
(1996)* 1.8 (1.1, 2.8) 
Updated original 
dataset 2.1 (1.3, 3.5) 
Multiply imputed 
dataset 1.7 (1.2, 2.5) 
Stage, tumor characteristics, 
treatment, hormonal and 
reproductive, Comorbidities and 
health behavior, sociodemographic 
Table 4, Hill et al 
(1996)* 1.6 (1.0, 2.6) 
Updated original 
dataset 1.3 (0.7, 2.6) 
Multiply imputed 
dataset 1.2 (0.9, 1.9) 
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Figure 1: Distribution of poverty index in original updated and imputed dataset 
0
5
10
15
20
25
30
35
40
45
50
0-125 126-200 201-300 >300
Fr
eq
ue
nc
y 
(%
)
Poverty Index
Original 
Updated Data 
N=320
Imputed Data 
N=490
 
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
0-125 126-200 201-300 >300
Fr
eq
ue
nc
y 
(%
)
Poverty index
Distribution of poverty index in original and imputed data by race
Original Updated Data 
White N=232
Imputed Data White N=341
Original Updated Data 
Black N=88
Imputed Data Black N=149
 
Figure 2: Distribution of poverty index in original updated and imputed dataset by race 
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APPENDIX A 
LIST OF INFORMATION FOR ALL VARIABLES IN THE ANALYSES 
Study Variable Data Source  Categories  Original Code Code used  
Race 
Medical 
record*  Black 
1 1 
    White 0 0 
Location Study Design Atlanta 1 1 
   New Orleans 2 2 
   San Fran/Oak 3 3 
Age Group Study Design 20-49 1 1 
   50-64 2 2 
   65-79 3 3 
Stage 
Medical 
record* Unknown 
V  
   1 1 1 
   2 2 2 
   3 3 3 
   4 4 4 
Interviewed Study Design No 0 0 
   Yes 1 1 
Grade 
Pathology 
Review Unknown 
V  
   1 1 1 
   2 2 2 
   3 3 3 
Comorbidity 
Medical 
record* Unknown 
V . 
   No 0 0 
   Yes 1 1 
Symptoms 
Medical 
record* Unknown 
V  
   No 0 0 
   Yes 1 1 
* Include medical records abstract and physician records 
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List of information for all variables in the analyses (continue) 
 
Study Variable Data Source  Categories  Original Code Code used  
Patient Delay Interview No 0 0 
   0-<1m 1 1 
   1-<3m 2 2 
   3-<6m 3 3 
   >=6m 4 4 
   Unknown . . 
Total Delay 
Interview + 
Medical 
record** 0-<1m 
1 1 
   1-<3m 2 2 
   3-<6m 3 3 
   >=6m 4 4 
   Unknown . . 
Smoking History Interview Never 0 0 
   Former 1 1 
   Current 2 2 
   Unknown . . 
Income Interview <10K 1 1 
   10-<20K 2 2 
   20-<35K 3 3 
   35K 4 4 
   Unknown . . 
Type of Insurance Interview None 0 0 
   Public 1 1 
   Any 2 2 
   Unknown . . 
Usual Source of Care Interview None 0 0 
   Public 1 1 
   Private 2 2 
   Unknown . . 
Poverty Index Interview 0-125 1 1 
   126-200 2 2 
   201-300 3 3 
   >301-400 4 4 
   >400 5 4 
   Unknown . . 
Occupation Class Interview Homemaker 0 5 
   Mgt/Prof 1 1 
   Tech/sales 2 2 
   Skilled 3 3 
   Unskilled 4 4 
   Unknown . . 
** Total delay was calculated by adding system delay, which was derived from medical records, and patient delay, which was derived 
from personal interviews. 
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List of information for all variables in the analyses (continue) 
 
Study Variable Data Source  Categories  Original Code Code used 
Education  Interview High School Grad 2 2 
   >High school 3 3 
   Unknown . . 
Marital Status Interview Partnered 1 1 
   Widowed 2 2 
   Div/Sep 3 3 
   Never married 6 4 
   Unknown . . 
Body Mass Index Quartile 
Medical 
record* Low normal 
1 1 
   High normal 2 2 
   Overweight 3 3 
   Very overweight 4 4 
   Unknown . . 
Histology 
Pathology 
review Others 
0 0 
   Adenosquamous 1 1 
Therapy 
Medical 
record* No Surgery 
NoSurgery 1 
   Surgery only SurgOnly 2 
  
 
Surgery plus 
SurgPlusChemo+ 
SurgPlusHormn++ 
SurgPlusCandH+++ 
SurgPlusRT** 
Surg_RT_CorH*** 
3 
  Unknown TRTUnkn . 
Oral Contraceptive Use Interview Not used 0 0 
   Used 1 1 
   Unknown . . 
Menopausal status 
Medical 
record* Premenopausal 
0 0 
   Postmenopausal 1 1 
   Unknown . . 
* Include medical records abstract and physician records 
+Surgery plus chemotherapy; ++Surgery plus hormonotherapy; +++ Surgery plus chemotherapy and hormonotherapy 
**Surgery plus radiotherapy; *** Surgery plus radiotherapy and either chemotherapy or hormonotherapy 
 
. 
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APPENDIX B 
GENERATION OF THE IMPUTATION CODE 
For total delay: 
Step 1:  Association between specified variables and total delay for cases with 
complete information 
Complete  
Contingency 
Coefficient 
Variables Race 0.03 
 Stage 0.15 
 Location 0.14 
 Age group 0.31 
 Grade 0.08 
 Symptoms 0.16 
 Histology 0.06 
 Menopausal status 0.25 
   
V2* Smoking history 0.16 
 Type of insurance 0.17 
  Education 0.17 
 Oral Contraceptive use 0.17 
 Usual Source of Care 0.19 
 Occupation Class 0.15 
    ＊Variables missing only because absence of interview 
 
  
 59 
 
Step 2: Log-linear models for subset of variables correlated with total delay 
Complete  Chi-Square Df p-value 
Variables Age group 30.76 6  <.0001 
 Menopausal status | Age group 1.49 3 0.68 
 Symptoms | Age group 1.38 2 0.50 
 Stage| Age group 9.38 9 0.40 
 Location | Age group 6.52 6 0.37 
 Grade | Age group 3.11 6 0.79 
 Histology | Age group 0.97 3 0.81 
 Race | Age group 0.33 3 0.95 
     
V2* Usual Source of Care | Age group 7.5 6 0.28 
 Oral Contraceptive use | Age group 0.8 3 0.85 
 Education| Age group 6.89 6 0.33 
 Insurance | Age group 6.11 6 0.41 
 Smoking hist | Age group 6.07 6 0.42 
 Occupation Class | Age group 6.78 12 0.87 
＊Variables missing only because absence of interview 
 
Use  
totdlygpcode=Survival time*100+Age group*10+Location*1 
to impute total delay 
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For patient delay: 
 
Impute patient delay as 0 for those symptoms equal to 0 
 
Step 1:  Association between specified variables and patient delay for cases with 
complete information 
Complete  
Contingency 
Coefficient 
Variables Race 0.13 
 Stage 0.13 
 Location 0.16 
 Age group 0.24 
 Grade 0.21 
 Symptoms 0.71 
 Histology 0.10 
 Menopausal status 0.19 
 
Step 2: Log-linear models for subset of variables correlated with patient delay 
  Chi-Square Df p-value 
Complete Age group 20.09 8 0.01 
Variables Grade | Age group 7.11 8 0.53 
 Menopausal | Age group 2.56 4 0.63 
 Location | Age group 7.67 8 0.47 
 Race | Age group 2.61 4 0.62 
 Stage | Age group 6.81 11 0.81 
 Histology | Age group 1.94 4 0.75 
 
Use 
ptdlygpcode= Survival time*100+ Age group*10+ Location*1 
to impute patient delay. 
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For smoking history: 
Step 1:  Association between specified variables and smoking history for cases 
with complete information 
Complete  
Contingency 
Coefficient 
Variables Race 0.11 
 Stage 0.13 
 Location 0.10 
 Age group 0.25 
 Grade 0.15 
 Symptoms 0.04 
 Histology 0.05 
 Menopausal status 0.11 
 
Step 2: Log-linear models for subset of variables correlated with smoking history 
  Chi-Square Df p-value 
Complete Age group 20.82 4 0.0003 
Variables Grade | Age group 10.06 4 0.0395 
 Stage | Age group, Grade 3.02 6 0.8067 
 Menopausal status | Age group, Grade 2.09 2 0.3512 
 Race | Age group, Grade 2.77 2 0.2504 
 Location | Age group, Grade 1.17 4 0.8824 
 Histology | Age group, Grade 2.22 2 0.3294 
 Symptoms | Age group, Grade 2.13 2 0.3447 
 
Use  
smkhxcode=Survival time*1000+Age group*100+Grade*10+Location*1 
to impute smoking history 
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For type of insurance: 
Step 1:  Association between specified variables and type of insurance for cases 
with complete information 
Complete  
Contingency 
Coefficient 
Variables Race 0.38 
 Stage 0.14 
 Location 0.21 
 Age group 0.32 
 Grade 0.15 
 Symptoms 0.02 
 Histology 0.17 
 Menopausal status 0.19 
 
Step 2: Log-linear models for subset of variables correlated with type of insurance 
  
Chi-
Square Df p-value 
Complete Race 55.01 2  <.0001 
Variables Age group| Race 26.61 4  <.0001 
 Location| Race, Age group 9.67 4 0.046 
 
Menopausal status | Race, Age group, 
Location 2.6 1 0.11 
 Histology| Race, Age group, Location 2.91 2 0.23 
 Grade | Race, Age group, Location 0.92 4 0.92 
 Stage | Race, Age group, Location 5.17 6 0.52 
 Symptoms | Race, Age group, Location 1.09 2 0.58 
 
Use 
insgpcode=Survival time*1000+ Race*100+ Age group*10+ Location*1 
to impute insurance. 
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For education: 
Step 1:  Association between specified variables and education for cases with 
complete information 
Complete  
Contingency 
Coefficient 
Variables Race 0.35 
 Stage 0.14 
 Location 0.23 
 Age group 0.23 
 Grade 0.17 
 Symptoms 0.05 
 Histology 0.16 
 Menopausal status 0.23 
 
Step 2: Log-linear models for subset of variables correlated with education 
  Chi-Square Df p-value 
Complete Race 45.39 2  <.0001 
Variables Menopausal status | Race 18.96 2  <.0001 
 Age group| Race, Menopausal status 1.52 4 0.82 
 Location| Race, Menopausal status 14.24 4 0.0066 
 Grade| Race, Menopausal status, Location 2.94 4 0.57 
 
Histology| Race, Menopausal status, 
Location 0.91 2 0.63 
 Stage| Race, Menopausal status, Location 1.67 6 0.95 
 
Symptoms| Race, Menopausal status, 
Location 0.67 2 0.72 
 
Use  
educcode= Survival time*1000+ Race*100+ Age group*10+ Location*1 
to impute education. 
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For oral contraceptive use: 
 
Step 1:  Association between specified variables and oral contraceptive use for 
cases with complete information 
Complete  
Contingency 
Coefficient 
Variables Race 0.14 
 Stage 0.14 
 Location 0.15 
 Age group 0.48 
 Grade 0.20 
 Symptoms 0.03 
 Histology 0.01 
 Menopausal status 0.48 
 
Step 2: Log-linear models for subset of variables correlated with oral 
contraceptive use 
  Chi-Square Df p-value 
Complete Menopausal status 82.15 1   <.0001 
Variables Age group | Menopausal status 16.93 2 0.0002 
 Grade | Menopausal status, Age group 8.24 2 0.016 
 
Location| Age group, Menopausal status, 
Grade 1.44 2 0.49 
 
Race | Age group, Menopausal status, 
Grade 3.19 1 0.074 
 
Stage | Age group, Menopausal status, 
Grade 1.96 3 0.58 
 
Symptoms | Age group, Menopausal 
status, Grade 0.87 1 0.35 
 
Histology | Age group, Menopausal 
status, Grade 0.01 1 0.94 
 
Use 
ocpcode=Survival time*1000+ Age group*100+ Menopausal status*10+ Grade*1 
to impute oral contraceptive use 
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For usual source of care: 
Step 1:  Association between specified variables and usual source of care for 
cases with complete information 
Complete  
Contingency 
Coefficient 
Variables Race 0.38 
 Stage 0.22 
 Location 0.22 
 Age group 0.18 
 Grade 0.10 
 Symptoms 0.04 
 Histology 0.14 
 Menopausal Status 0.14 
 
Step 2: Log-linear models for subset of variables correlated with oral 
contraceptive use 
  Chi-Square Df p-value 
Complete Race 42.51 2  <.0001 
Variables Stage | Race 16.21 6 0.013 
 Location | Race, Stage 13.53 4 0.009 
 Age group | Race, Stage, Location 10.25 4 0.036 
 
Histology | Race, Stage, Location, Age 
group 0.16 2 0.92 
 
Menopausal status | Race, Stage, 
Location, Age group 0.67 2 0.71 
 
Grade | Race, Stage, Location, Age 
group 5.87 4 0.21 
 
Symptoms | Race, Stage, Location, Age 
group 1.63 2 0.44 
 
Use 
ucgpcode=Survivaltime*10000+Race*1000+Stage*100+Location*10+Agegroup*1 
to impute usual source of care 
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For occupation class: 
 
Step 1:  Association between specified variables and occupation class for cases 
with complete information 
Complete  
Contingency 
Coefficient 
Variables Race 0.40 
 Stage 0.27 
 Location 0.25 
 Age group 0.25 
 Grade 0.25 
 Symptoms 0.07 
 Histology 0.20 
 Menopausal Status 0.23 
 
Step 2: Log-linear models for subset of variables correlated with occupation class 
  Chi-Square Df p-value 
Complete Race 61.08 4  <.0001 
Variables Stage | Race 11.97 11 0.37 
 Location | Race 22.28 8 0.0044 
 Age group | Race, Location 12.17 8 0.14 
 Grade | Race, Location 6.54 8 0.59 
 Menopausal status | Race, Location 4.24 4 0.37 
 Histology | Race, Location 8.26 4 0.082 
 Symptoms | Race, Location 2.99 4 0.56 
 
Use 
occupcode= Survival time*1000+ Race*100+ Location*10+ Age group*1 
to impute occupation class. 
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For comorbidity: 
 
Step 1:  Association between specified variables and comorbidity for cases with 
complete information 
Complete  
Contingency 
Coefficient 
Variables Race 0.20 
 Stage 0.09 
 Location 0.07 
 Age group 0.22 
 Grade 0.09 
 Symptoms 0.03 
 Histology 0.08 
 Menopausal Status 0.22 
 
Step 2: Log-linear models for subset of variables correlated with comorbidity 
  Chi-Square Df p-value 
Complete Menopausal status 20.38 1   <.0001 
Variables Age group | Menopausal status 0.52 2 0.77 
 Race | Menopausal status 17.11 1  <.0001 
 Stage | Menopausal status, Race 2.15 3 0.54 
 Grade | Menopausal status, Race 1.22 2 0.54 
 Histology | Menopausal status, Race 7.32 1 0.0068 
 
Location | Menopausal status, Race, 
Histology 2.52 2 0.28 
 
Symptoms | Menopausal status, Race, 
Histology 0 1 0.97 
 
Use 
comorbscode= Survival time*1000+ Age group*100+ Race*10+Histology*1 
to impute comorbidity. 
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For BMI: 
Step 1:  Association between specified variables and BMI for cases with complete 
information 
Complete  
Contingency 
Coefficient 
Variables Race 0.38 
 Stage 0.19 
 Location 0.22 
 Age group 0.14 
 Grade 0.15 
 Symptoms 0.06 
 Histology 0.15 
 Menopausal Status 0.12 
 
Step 2: Log-linear models for subset of variables correlated with BMI 
  Chi-Square Df p-value 
Complete Race 57.87 3   <.0001 
Variables Location | Race 13.03 6 0.0426 
 Stage | Race, Location 4.18 9 0.8993 
 Grade| Race, Location 5.09 6 0.5329 
 Histology | Race, Location 2.14 3 0.5431 
 Age group | Race, Location 6.04 6 0.4182 
 Menopausal status | Race, Location 4.92 3 0.1775 
 Symptoms | Race, Location 1.08 3 0.7828 
 
Use 
bmiqcode= Survival time*1000+ Race*100+ Location*10+ Age group*1 
to impute BMI  
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For treatment: 
 Step 1:  Association between specified variables and treatment for cases with 
complete information 
Complete  
Contingency 
Coefficient 
Variables Race 0.31 
 Stage 0.43 
 Location 0.20 
 Age group 0.13 
 Grade 0.41 
 Symptoms 0.09 
 Histology 0.20 
 Menopausal Status 0.12 
 
Step 2: Log-linear models for subset of variables correlated with treatment 
  Chi-Square Df p-value 
Complete Stage 58.75 6    <.0001 
Variables Grade| Stage 27.94 6  <.0001 
 Race| Stage, Grade 14.55 2 0.0007 
 Location | Stage, Grade, Race 12.65 4 0.013 
 Histology | Stage, Grade, Race, Location 1.2 2 0.55 
 Age group | Stage, Grade, Race, Location 1.16 4 0.88 
 
Menopausal status | Stage, Grade, Race, 
Location 1.29 2 0.52 
 Symptoms | Stage, Grade, Race, Location 0.18 1 0.67 
 
Use 
therapycode= Survival time*10000+ Stage*1000+ Grade*100+ Race*10+ Location*1 
to impute treatment 
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APPENDIX C 
SAS CODE FOR THE GENERATION OF IMPUTATION CODE AND R CODE 
FOR MULTIPLE IMPUTATION 
C.1 SAS CODE FOR THE GENERATION IMPUTATION CODE 
 
*For generation imputation code; 
*First, look at the missing distribution; 
proc sort data=sasuser.labeled_dum; 
by race; 
run; 
proc freq data=sasuser.labeled_dum; 
by race; 
table  
inques*ptdlygpM 
inques*totdlygpM 
inques*smkhxM 
inques*incgpM 
inques*insgpM 
inques*ucgpM 
inques*povgpM 
inques*occupM 
inques*educM 
inques*ocpM 
; 
run; 
 
* Impute almost complete variables; 
 
*Ass ciato ion between menostat and agegp; 
proc freq data=sasuser.impute; 
tables menostat*agegp/cmh; 
run; 
proc freq data=sasuser.impute; 
tables menostatM*agegp; 
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run; 
 
Data sasuser.baseline; 
set sasuser.labeledm; 
if survtime=<12 then st2=1; 
else if survtime=<36 & survtime >12 then st2=2; 
else if survtime=<60 & survtime >36 then st2=3; 
else st2=4; 
if stage=. then stageM=1 else stageM=0 ; ; 
if grade=. then gradeM=1; else gradeM=0; 
proc freq; 
tables stage*st2 stageM*st2 grade*st2 gradeM*st2/chisq cmh; 
run; 
data t; 
set sasuser.labeledm; 
if symptoms=0 then symptomsM=0;  
else if symptoms=1 then symptomsM=0; 
else symptomsM=1; 
run; 
proc freq; 
tables symptomsM*ptdlygp; 
run; 
proc freq data=sasuser.labeled_dum; 
table menostatM*agegp; 
run; 
 
* Merge variables to avoid sparse data; 
data sasuser.impute; 
set sasuser.impute; 
if povgp=1 the 1; n povgp=
else if povgp=2 then povgp=2; 
else if povgp=3 then povgp=3; 
else if povgp=4 then povgp=4 ; 
else if povgp=5 then povgp=4; 
else povgp=.; 
if stage=. then stage=1;  
if grade=.& st2=1 then grade=3; 
else if grade=. & st2=3 then grade=3; 
else if grade=. & st2=4 then rade=1;  g
if symptoms=. then symptoms=1; 
if menostat=.& agegp=1 then menostat=1; 
else if menostat=. & agegp=2 then menostat=2; 
run; 
proc freq; 
table povgp*race; 
run; 
 
*1. Povery index; 
* pairwise correlation with basic variales by contingency table
 analysis for poverty index; 
proc freq; 
table povgp*race/chisq cmh; 
run; 
proc freq; 
table povgp*stage/chisq cmh; 
run; 
proc freq; 
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table povgp*locn/chisq cmh; 
run; 
proc freq; 
table povgp*agegp/chisq cmh; 
run; 
proc freq; 
table povgp*grade/chisq cmh; 
run; 
proc freq; 
table povgp*symptoms/chisq cmh; 
run; 
proc freq; 
table povgp*Histcat/chisq cmh; 
run; 
proc freq; 
table povgp*MENOSTAT/chisq cmh; 
run; 
* Pa rwisi e with V2 for poverty index; 
proc freq; 
table povgp*smkhx/chisq cmh; 
run  ;
proc freq; 
table povgp*insgp/chisq cmh; 
run  ;
proc freq; 
table povgp*educ/chisq cmh; 
run  ;
proc freq; 
table povgp*OCP/chisq cmh; 
run  ;
proc freq; 
table povgp*ucgp/chisq cmh; 
run  ;
proc freq; 
table povgp*occup/chisq cmh; 
run; 
 
* loglinear models with baseline variables for poverty index; 
proc catmod; 
model povgp*race=_response_; 
loglin povgp|race; 
run  ;
proc catmod; 
model povgp*race*locn=_response_; 
loglin povgp|race|locn @2; 
run; 
proc catmod; 
model povgp*race*locn*grade=_response_ / noparm; 
loglin povgp|race|locn|grade @2; 
run; 
proc catmod; 
model povgp*race*locn*stage=_response_ / noparm; 
loglin povgp|race|locn|stage @2; 
run; 
proc catmod; 
model povgp*race*locn*agegp=_response_ / noparm; 
loglin povgp|race|locn|agegp @2; 
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run; 
proc catmod; 
model povgp*race*locn*agegp*histcat=_response_ / noparm; 
loglin povgp|race|locn|agegp|histcat @2; 
run; 
proc catmod; 
model povgp*race*locn*agegp*menostat=_response_ / noparm; 
loglin povgp|race|locn|agegp|menostat @2; 
run  ;
proc catmod; 
model povgp*race*locn*agegp*symtoms=_response_ / noparm; 
loglin povgp|race|locn|agegp|symtoms @2; 
run; 
 
* lo linearg  models with V2 variables for poverty index; 
proc catmod; 
model povgp*locn*race*agegp*occup=_response_ /noparm; 
loglin povgp|agegp|race|locn|occup @2; 
run; 
proc catmod; 
model povgp*locn*race*agegp*occup*insgp=_response_ /noparm; 
loglin povgp|locn|race|agegp|occup|insgp @2; 
run; 
proc catmod; 
model povgp*locn*race*agegp*occup*educ=_response_ /noparm; 
loglin povgp|locn|race|agegp|occup|educ @2; 
run  ;
proc catmod; 
model povgp*locn*race*agegp*occup*ucgp=_response_ /noparm; 
loglin povgp|locn|race|agegp|occup|ucgp @2; 
run; 
proc catmod; 
model povgp*locn*race*agegp*occup*ocp=_response_ /noparm; 
loglin povgp|locn|race|agegp|occup|ocp @2; 
run; 
proc catmod; 
model povgp*locn*race*agegp*occup*smkhx=_response_ /noparm; 
loglin povgp|locn|race|agegp|occup|smkhx @2; 
run; 
 
*Prepare for imputation; 
proc freq data=sasuser.impute; 
table povgpM*occupM; 
run; 
proc corr; 
var occup educ; 
run; 
proc sort data=sasuser.impute; 
by locn race; 
proc freq; 
tables occup*povgp; 
by race; 
run; 
proc freq; 
tables occup*povgp; 
run; 
proc freq; 
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tables occup*povgp; 
by locn; 
run; 
proc freq; 
tables occup*povgp; 
by locn race; 
run; 
 
data sasuser.impute; 
set sasuser.impute; 
id=_N_; 
povgpcode=st2*10000+race*1000+locn*100+agegp*10+occup*1; 
povgpcode2=st2*1000+race*100+locn*10+agegp*1; 
run; 
 
*2. Total delay; 
* pairwise correlation with basic variales by contingency table
 y for total delay; anal sis 
proc freq; 
table totdlygp*race/chisq cmh; 
run  ;
proc freq; 
table totdlygp*stage/chisq cmh; 
run  ;
proc freq; 
table totdlygp*locn/chisq cmh; 
run  ;
proc freq; 
table totdlygp*agegp/chisq cmh; 
run  ;
proc freq; 
table totdlygp*grade/chisq cmh; 
run  ;
proc freq; 
table totdlygp*symptoms/chisq cmh; 
run  ;
proc freq; 
table totdlygp*Histcat/chisq cmh; 
run  ;
proc freq; 
table totdlygp*MENOSTAT/chisq cmh; 
run; 
* Pairwise with V2 for total delay; 
proc freq; 
table totdlygp*smkhx/chisq cmh; 
run; 
proc freq; 
table totdlygp*insgp/chisq cmh; 
run; 
proc freq; 
table totdlygp*educ/chisq cmh; 
run; 
proc freq; 
table totdlygp*OCP/chisq cmh; 
run; 
proc freq; 
table totdlygp*ucgp/chisq cmh; 
 75 
run; 
proc freq; 
table totdlygp*occup/chisq cmh; 
run; 
* lo linearg  models with baseline variables for total delay; 
proc catmod; 
model totdlygp*agegp=_response_; 
loglin totdlygp|agegp; 
run  ;
proc catmod; 
model totdlygp*agegp*menostat=_response_ / noparm; 
loglin totdlygp|agegp|menostat @2; 
run; 
proc catmod; 
model totdlygp*agegp*symptoms=_response_ / noparm; 
loglin totdlygp|symptoms|agegp @2; 
run; 
proc catmod; 
model totdlygp*agegp*stage=_response_ / noparm; 
loglin totdlygp|agegp|stage @2; 
run  ;
proc catmod; 
model totdlygp*agegp*locn=_response_ / noparm; 
loglin totdlygp|agegp|locn @2; 
run; 
proc catmod; 
model totdlygp*agegp*grade=_response_ / noparm; 
loglin totdlygp|agegp|grade @2; 
run; 
proc catmod; 
model totdlygp*agegp*histcat=_response_ / noparm; 
loglin totdlygp|agegp|histcat @2; 
run  ;
proc catmod; 
model totdlygp*agegp*race=_response_ / noparm; 
loglin totdlygp|agegp|race @2; 
run; 
* loglinear models with V2 variables for total delay; 
proc catmod; 
model totdlygp*agegp*ucgp=_response_ /noparm; 
loglin totdlygp|agegp|ucgp @2; 
run  ;
proc catmod; 
model totdlygp*agegp*ocp=_response_ /noparm; 
loglin totdlygp|agegp|ocp @2; 
run; 
proc catmod; 
model totdlygp*agegp*educ=_response_ /noparm; 
loglin totdlygp|agegp|educ @2; 
run; 
proc catmod; 
model totdlygp*agegp*insgp=_response_ /noparm; 
loglin totdlygp|agegp|insgp @2; 
run; 
proc catmod; 
model totdlygp*agegp*smkhx=_response_ /noparm; 
loglin totdlygp|agegp|smkhx @2; 
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run; 
proc catmod; 
model totdlygp*agegp*occup=_response_ /noparm; 
loglin totdlygp|agegp|occup @2; 
run; 
 
*Prepare for imputation; 
data sasuser.impute; 
set sasuser.impute; 
totdlygpcode=st2*100+Agegp*10+locn*1; 
run; 
 
* 3. Smoking history; 
* pairwise correlation with basic variales by contingency table
 y for smoking history; anal sis 
proc freq; 
table smkhx*race/chisq cmh; 
run  ;
proc freq; 
table smkhx*stage/chisq cmh; 
run  ;
proc freq; 
table smkhx*locn/chisq cmh; 
run  ;
proc freq; 
table smkhx*agegp/chisq cmh; 
run  ;
proc freq; 
table smkhx*grade/chisq cmh; 
run  ;
proc freq; 
table smkhx*symptoms/chisq cmh; 
run  ;
proc freq; 
table smkhx*Histcat/chisq cmh; 
run  ;
proc freq; 
table smkhx*MENOSTAT/chisq cmh; 
run; 
 
* loglinear models with baseline variables for smoking history; 
proc catmod; 
model smkhx*agegp=_response_; 
loglin smkhx|agegp; 
run; 
proc catmod; 
model smkhx*agegp*grade=_response_ / noparm; 
loglin smkhx|agegp|grade @2; 
run; 
proc catmod; 
model smkhx*agegp*grade*stage=_response_ / noparm; 
loglin smkhx|agegp|grade|stage @2; 
run; 
proc catmod; 
model smkhx*agegp*grade*menostat=_response_ / noparm; 
loglin smkhx|agegp|grade|menostat @2; 
run; 
 77 
proc catmod; 
model smkhx*agegp*grade*race=_response_ / noparm; 
loglin smkhx|agegp|grade|race @2; 
run; 
proc catmod; 
model smkhx*agegp*grade*locn=_response_ / noparm; 
loglin smkhx|agegp|grade|locn @2; 
run; 
proc catmod; 
model smkhx*agegp*grade*histcat=_response_ / noparm; 
loglin smkhx|agegp|grade|histcat @2; 
run; 
proc catmod; 
model smkhx*agegp*grade*symptoms=_response_ / noparm; 
loglin smkhx|agegp|grade|symptoms @2; 
run; 
 
*Prepare for imputation; 
data sasuser.impute; 
set sasuser.impute; 
smkhxcode=st2*1000+Agegp*100+grade*10+locn*1; 
run; 
 
*4. Insurance; 
* pairwise correlation with basic variales by contingency table
 y for insurance; anal sis 
proc freq; 
table insgp*race/chisq cmh; 
run; 
proc freq; 
table insgp*stage/chisq cmh; 
run; 
proc freq; 
table insgp*locn/chisq cmh; 
run; 
proc freq; 
table insgp*agegp/chisq cmh; 
run; 
proc freq; 
table insgp*grade/chisq cmh; 
run; 
proc freq; 
table insgp*symptoms/chisq cmh; 
run; 
proc freq; 
table insgp*Histcat/chisq cmh; 
run; 
proc freq; 
table insgp*MENOSTAT/chisq cmh; 
run; 
 
* loglinear models with baseline variables for insurance; 
proc catmod; 
model insgp*race=_response_; 
loglin insgp|race; 
run; 
proc catmod; 
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model insgp*race*agegp=_response_ / noparm; 
loglin insgp|race|agegp @2; 
run; 
proc catmod; 
model insgp*race*agegp*locn=_response_ / noparm; 
loglin insgp|race|agegp|locn @2; 
run; 
proc catmod; 
model insgp*race*agegp*locn*menostat=_response_ / noparm; 
loglin insgp|race|agegp|locn|menostat @2; 
run; 
proc catmod; 
model insgp*race*agegp*locn*histcat=_response_ / noparm; 
loglin insgp|race|agegp|locn|histcat @2; 
run  ;
proc catmod; 
model insgp*race*agegp*locn*grade=_response_ / noparm; 
loglin insgp|race|agegp|locn|grade @2; 
run; 
proc catmod; 
model insgp*race*agegp*locn*stage=_response_ / noparm; 
loglin insgp|race|agegp|locn|stage @2; 
run; 
proc catmod; 
model insgp*race*locn*agegp*symptoms=_response_ / noparm; 
loglin insgp|race|locn|agegp|symptoms @2; 
run; 
 
*Prepare for imputation; 
data sasuser.impute; 
set sasuser.impute; 
insgpcode=st2*1000+race*100+agegp*10+locn*1; 
run; 
 
*5. Education; 
* pairwise correlation with basic variales by contingency table
 analysis for Education; 
proc freq; 
table educ*race/chisq cmh; 
run; 
proc freq; 
table educ*stage/chisq cmh; 
run; 
proc freq; 
table educ*locn/chisq cmh; 
run; 
proc freq; 
table educ*agegp/chisq cmh; 
run; 
proc freq; 
table educ*grade/chisq cmh; 
run; 
proc freq; 
table educ*symptoms/chisq cmh; 
run; 
proc freq; 
table educ*Histcat/chisq cmh; 
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run; 
proc freq; 
table educ*MENOSTAT/chisq cmh; 
run; 
 
* loglinear models with baseline variables for education; 
proc catmod; 
model educ*race=_response_; 
loglin educ|race; 
run; 
proc catmod; 
model educ*race*menostat=_response_ / noparm; 
loglin educ|race|menostat @2; 
run; 
proc catmod; 
model educ*race*menostat*agegp=_response_ / noparm; 
loglin educ|race|menostat|agegp @2; 
run  ;
proc catmod; 
model educ*race*menostat*locn=_response_ / noparm; 
loglin educ|race|menostat|locn @2; 
run; 
proc catmod; 
model educ*race*menostat*locn*grade=_response_ / noparm; 
loglin educ|race|menostat|locn|grade @2; 
run; 
proc catmod; 
model educ*race*menostat*locn*histcat=_response_ / noparm; 
loglin educ|race|menostat|locn|histcat @2; 
run  ;
proc catmod; 
model educ*race*menostat*locn*stage=_response_ / noparm; 
loglin educ|race|menostat|locn|stage @2; 
run; 
proc catmod; 
model educ*race*menostat*locn*symptoms=_response_ / noparm; 
loglin educ|race|menostat|locn|symptoms @2; 
run; 
 
*Prepare for imputation; 
data sasuser.impute; 
set sasuser.impute; 
educcode=st2*1000+race*100+agegp*10+locn*1; 
run; 
 
*6. Oral contraceptive use; 
* pairwise correlation with basic variales by contingency table
 y for OCP; anal sis 
proc freq; 
table ocp*race/chisq cmh; 
run; 
proc freq; 
table ocp*stage/chisq cmh; 
run; 
proc freq; 
table ocp*locn/chisq cmh; 
run; 
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proc freq; 
table ocp*agegp/chisq cmh; 
run; 
proc freq; 
table ocp*grade/chisq cmh; 
run; 
proc freq; 
table ocp*symptoms/chisq cmh; 
run  ;
proc freq; 
table ocp*Histcat/chisq cmh; 
run; 
proc freq; 
table ocp*MENOSTAT/chisq cmh; 
run; 
 
* lo linearg  models with baseline variables for ocp; 
proc catmod; 
model ocp*menostat=_response_; 
loglin ocp|menostat; 
run  ;
proc catmod; 
model ocp*menostat*agegp=_response_ / noparm; 
loglin ocp|menostat|agegp @2; 
run; 
proc catmod; 
model ocp*agegp*menostat*grade=_response_ / noparm; 
loglin ocp|agegp|menostat|grade @2; 
run; 
proc catmod; 
model ocp*agegp*menostat*grade*locn=_response_ / noparm; 
loglin ocp|agegp|menostat|grade|locn @2; 
run  ;
proc catmod; 
model ocp*agegp*menostat*grade*race=_response_ / noparm; 
loglin ocp|agegp|menostat|grade|race @2; 
run; 
proc catmod; 
model ocp*agegp*menostat*grade*stage=_response_ / noparm; 
loglin ocp|agegp|menostat|grade|stage @2; 
run; 
proc catmod; 
model ocp*agegp*menostat*grade*symptoms=_response_ / noparm; 
loglin ocp|agegp|menostat|grade|symptoms @2; 
run; 
proc catmod; 
model  ocp*agegp*menostat*grade*histcat=_response_ / noparm; 
loglin  ocp|agegp|menostat|grade|histcat @2; 
run; 
 
*Prepare for imputation; 
data sasuser.impute; 
set sasuser.impute; 
ocpcode=st2*1000+agegp*100+menostat*10+grade*1; 
run; 
 
*7. Usual source of care; 
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* pairwise correlation with basic variales by contingency table
 y for usual source of care; anal sis 
proc freq; 
table ucgp*race/chisq cmh; 
run; 
proc freq; 
table ucgp*stage/chisq cmh; 
run; 
proc freq; 
table ucgp*locn/chisq cmh; 
run; 
proc freq; 
table ucgp*agegp/chisq cmh; 
run; 
proc freq; 
table ucgp*grade/chisq cmh; 
run; 
proc freq; 
table ucgp*symptoms/chisq cmh; 
run; 
proc freq; 
table ucgp*Histcat/chisq cmh; 
run; 
proc freq; 
table ucgp*MENOSTAT/chisq cmh; 
run; 
 
* loglinear models with baseline variables for usual source of 
care; 
proc catmod; 
model ucgp*race=_response_; 
loglin ucgp|race; 
run  ;
proc catmod; 
model ucgp*race*stage=_response_ / noparm; 
loglin ucgp|race|stage @2; 
run; 
proc catmod; 
model ucgp*race*stage*locn=_response_ / noparm; 
loglin ucgp|race|stage|locn @2; 
run; 
proc catmod; 
model ucgp*race*stage*locn*agegp=_response_ / noparm; 
loglin ucgp|race|stage|locn|agegp @2; 
run; 
proc catmod; 
model ucgp*race*stage*locn*agegp*histcat=_response_ / noparm; 
loglin ucgp|race|stage|locn|agegp|histcat @2; 
run; 
proc catmod; 
model ucgp*race*stage*locn*agegp*menostat=_response_ / noparm; 
loglin ucgp|race|stage|locn|agegp|menostat @2; 
run; 
proc catmod; 
model ucgp*race*stage*locn*agegp*grade=_response_ / noparm; 
loglin ucgp|race|stage|locn|agegp|grade @2; 
run; 
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proc catmod; 
model ucgp*race*stage*locn*agegp*symptoms=_response_ / noparm; 
loglin ucgp|race|stage|locn|agegp|symptoms @2; 
run; 
 
*Prepare for imputation; 
data sasuser.impute; 
set sasuser.impute; 
ucgpcode=st2*10000+race*1000+stage*100+locn*10+Agegp*1; 
run; 
 
*8. Occupation class; 
* pairwise correlation with basic variales by contingency table
 y for occupation class; anal sis 
proc freq; 
table occup*race/chisq cmh; 
run; 
proc freq; 
table occup*stage/chisq cmh; 
run; 
proc freq; 
table occup*locn/chisq cmh; 
run; 
proc freq; 
table occup*agegp/chisq cmh; 
run; 
proc freq; 
table occup*grade/chisq cmh; 
run; 
proc freq; 
table occup*symptoms/chisq cmh; 
run; 
proc freq; 
table occup*Histcat/chisq cmh; 
run; 
proc freq; 
table occup*MENOSTAT/chisq cmh; 
run; 
 
* loglinear models with baseline variables for occupaton class; 
proc catmod; 
model occup*race=_response_; 
loglin occup|race; 
run; 
proc catmod; 
model occup*race*stage=_response_ / noparm; 
loglin occup|race|stage @2; 
run  ;
proc catmod; 
model occup*race*locn=_response_ / noparm; 
loglin occup|race|locn @2; 
run; 
proc catmod; 
model occup*race*locn*agegp=_response_ / noparm; 
loglin occup|race|locn|agegp @2; 
run; 
proc catmod; 
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model occup*race*locn*grade=_response_ / noparm; 
loglin occup|race|locn|grade @2; 
run; 
proc catmod; 
model occup*race*locn*menostat=_response_ / noparm; 
loglin occup|race|locn|menostat @2; 
run; 
proc catmod; 
model occup*race*locn*histcat=_response_ / noparm; 
loglin occup|race|locn|histcat @2; 
run; 
proc catmod; 
model occup*race*locn*symptoms=_response_ / noparm; 
loglin occup|race|locn|symptoms @2; 
run; 
 
*Prepare for imputation; 
data sasuser.impute; 
set sasuser.impute; 
occupcode=st2*1000+race*100+locn*10+agegp*1; 
run; 
 
* Others: 
*9. Comorbidity; 
* pairwise correlation with basic variales by contingency table
 y for comorbidity; anal sis 
proc freq; 
table comorbs*race/chisq cmh; 
run; 
proc freq; 
table comorbs*stage/chisq cmh; 
run; 
proc freq; 
table comorbs*locn/chisq cmh; 
run; 
proc freq; 
table comorbs*agegp/chisq cmh; 
run; 
proc freq; 
table comorbs*grade/chisq cmh; 
run; 
proc freq; 
table comorbs*symptoms/chisq cmh; 
run; 
proc freq; 
table comorbs*Histcat/chisq cmh; 
run; 
proc freq; 
table comorbs*MENOSTAT/chisq cmh; 
run; 
 
* loglinear models with baseline variables for comorbidity; 
proc catmod; 
model comorbs*menostat=_response_; 
loglin comorbs|menostat; 
run; 
proc catmod; 
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model comorbs*menostat*agegp=_response_ / noparm; 
loglin comorbs|menostat|agegp @2; 
run; 
proc catmod; 
model comorbs*menostat*race=_response_ / noparm; 
loglin comorbs|menostat|race @2; 
run; 
proc catmod; 
model comorbs*menostat*race*stage=_response_ / noparm; 
loglin comorbs|menostat|race|stage @2; 
run; 
proc catmod; 
model comorbs*menostat*race*grade=_response_ / noparm; 
loglin comorbs|menostat|race|grade @2; 
run  ;
proc catmod; 
model comorbs*menostat*race*histcat=_response_ / noparm; 
loglin comorbs|menostat|race|histcat @2; 
run; 
proc catmod; 
model comorbs*menostat*race*histcat*locn=_response_ / noparm; 
loglin comorbs|menostat|race|histcat|locn @2; 
run; 
proc catmod; 
model comorbs*menostat*race*histcat*symptoms=_response_ / noparm; 
loglin comorbs|menostat|race|histcat|symptoms @2; 
run; 
 
*Prepare for imputation; 
data sasuser.impute; 
set sasuser.impute; 
comorbscode=st2*1000+agegp*100+race*10+histcat*1; 
run; 
 
*9. BMI; 
* pairwise correlation with basic variales by contingency table
 analysis for BMI; 
proc freq; 
table bmiq*race/chisq cmh; 
run; 
proc freq; 
table bmiq*stage/chisq cmh; 
run; 
proc freq; 
table bmiq*locn/chisq cmh; 
run; 
proc freq; 
table bmiq*agegp/chisq cmh; 
run; 
proc freq; 
table bmiq*grade/chisq cmh; 
run; 
proc freq; 
table bmiq*symptoms/chisq cmh; 
run; 
proc freq; 
table bmiq*Histcat/chisq cmh; 
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run; 
proc freq; 
table bmiq*MENOSTAT/chisq cmh; 
run; 
 
* loglinear models with baseline variables for occupaton class; 
proc catmod; 
model bmiq*race=_response_; 
loglin bmiq|race; 
run; 
proc catmod; 
model bmiq*race*locn=_response_ / noparm; 
loglin bmiq|race|locn @2; 
run; 
proc catmod; 
model bmiq*race*locn*stage=_response_ / noparm; 
loglin  bmiq|race|locn|stage @2; 
run  ;
proc catmod; 
model bmiq*race*locn*grade=_response_ / noparm; 
loglin bmiq|race|locn|grade @2; 
run; 
proc catmod; 
model bmiq*race*locn*histcat=_response_ / noparm; 
loglin bmiq|race|locn|histcat @2; 
run; 
proc catmod; 
model bmiq*race*locn*agegp=_response_ / noparm; 
loglin bmiq|race|locn|agegp @2; 
run  ;
proc catmod; 
model bmiq*race*locn*menostat=_response_ / noparm; 
loglin bmiq|race|locn|menostat @2; 
run; 
proc catmod; 
model bmiq*race*locn*symptoms=_response_ / noparm; 
loglin bmiq|race|locn|symptoms @2; 
run; 
 
*Prepare for imputation; 
data sasuser.impute; 
set sasuser.impute; 
bmiqcode=st2*1000+race*100+locn*10+agegp*1; 
run; 
 
*9. Patient delay; 
* pairwise correlation with basic variales by contingency table
 y for Patient delay; anal sis 
proc freq; 
table ptdlygp*race/chisq cmh; 
run; 
proc freq; 
table ptdlygp*stage/chisq cmh; 
run; 
proc freq; 
table ptdlygp*locn/chisq cmh; 
run; 
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proc freq; 
table ptdlygp*agegp/chisq cmh; 
run; 
proc freq; 
table ptdlygp*grade/chisq cmh; 
run; 
proc freq; 
table ptdlygp*symptoms/chisq cmh; 
run  ;
proc freq; 
table ptdlygp*Histcat/chisq cmh; 
run; 
proc freq; 
table ptdlygp*MENOSTAT/chisq cmh; 
run; 
 
* lo linearg  models with baseline variables for Patient delay; 
proc catmod; 
model ptdlygp*symptoms=_response_; 
loglin ptdlygp|symptoms; 
run  ;
proc freq; 
tables ptdlygp*symptoms; 
run  ;
data sasuser.impute; 
set sasuser.impute; 
if symptoms=0 then ptdlygp=0; 
run; 
proc catmod; 
model ptdlygp*agegp=_response_ / noparm; 
loglin ptdlygp|agegp @2; 
run; 
proc catmod; 
model ptdlygp*agegp*grade=_response_ / noparm; 
loglin  ptdlygp|agegp|grade @2; 
run  ;
proc catmod; 
model ptdlygp*agegp*menostat=_response_ / noparm; 
loglin ptdlygp|agegp|menostat @2; 
run; 
proc catmod; 
model  ptdlygp*agegp*locn=_response_ / noparm; 
loglin ptdlygp|agegp|locn @2; 
run; 
proc catmod; 
model ptdlygp*agegp*race=_response_ / noparm; 
loglin ptdlygp|agegp|race @2; 
run  ;
proc catmod; 
model ptdlygp*agegp*stage=_response_ / noparm; 
loglin ptdlygp|agegp|stage @2; 
run; 
proc catmod; 
model ptdlygp*agegp*histcat=_response_ / noparm; 
loglin ptdlygp|agegp|histcat @2; 
run; 
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*Prepare for imputation; 
data sasuser.impute; 
set sasuser.impute; 
ptdlygpcode=st2*100+agegp*10+locn*1; 
run; 
 
*10. Therapy; 
* pairwise correlation with basic variales by contingency table
 y for Therapy; anal sis 
proc freq; 
table therapy*race/chisq cmh; 
run; 
proc freq; 
table therapy*stage/chisq cmh; 
run  ;
proc freq; 
table therapy*locn/chisq cmh; 
run  ;
proc freq; 
table therapy*agegp/chisq cmh; 
run  ;
proc freq; 
table therapy*grade/chisq cmh; 
run  ;
proc freq; 
table therapy*symptoms/chisq cmh; 
run  ;
proc freq; 
table therapy*Histcat/chisq cmh; 
run  ;
proc freq; 
table therapy*MENOSTAT/chisq cmh; 
run; 
 
* loglinear models with baseline variables for therapy; 
proc catmod; 
model therapy*stage=_response_; 
loglin therapy|stage; 
run  ;
proc catmod; 
model therapy*stage*grade=_response_ / noparm; 
loglin therapy|stage|grade @2; 
run; 
proc catmod; 
model therapy*stage*grade*race=_response_ / noparm; 
loglin therapy|stage|grade|race @2; 
run; 
proc catmod; 
model therapy*stage*grade*race*locn=_response_ / noparm; 
loglin  therapy|stage|grade|race|locn @2; 
run; 
proc catmod; 
model therapy*stage*grade*race*locn*histcat=_response_ / noparm; 
loglin therapy|stage|grade|race|locn|histcat @2; 
run; 
proc catmod; 
model  therapy*stage*grade*race*locn*agegp=_response_ / noparm; 
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loglin therapy|stage|grade|race|locn|agegp @2; 
run; 
proc catmod; 
model therapy*stage*grade*race*locn*menostat=_response_ / noparm; 
loglin therapy|stage|grade|race|locn|menostat @2; 
run; 
proc catmod; 
model therapy*stage*grade*race*locn*symptoms=_response_ / noparm; 
loglin therapy|stage|grade|race|locn|symptoms @2; 
run; 
 
 
*Prepare for imputation; 
data sasuser.impute; 
set sasuser.impute; 
therapycode=st2*10000+stage*1000+grade*100+race*10+locn*1; 
run; 
 
C.2 R CODE FOR MULTIPLE IMPUTAION 
library(gdata) 
data<-read.xls("/Users/Eva/Documents/data.xls",sheet=1,verbose=F) 
 
# Hot-deck imputation 
 
searchcloseby<-function(value,set) 
 {  
  distance<-abs(value-set) 
   
  w<-cbind(distance,set) 
  w1<-w[order(w[,1]),1:2] 
   
  closevalue<-as.numeric(w1[1,2]) 
  #cat(value,closevalue,"\n\n\n") 
  closevalue 
  } 
 
#1.Poverty index 
 
#first 51 subjects 
 
 
povgpimpute1<-function(dataset,dataout) 
{ 
 #dataset<-data 
 mdvector<-
dataset$id[dataset$povgpM==1&is.na(dataset$povgpcode)==F] # 51 obs 
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 codeset<-dataset$povgpcode[dataset$povgpM==0] # 320 obs 
   
 codeset<-sort(codeset) # get rid of the missing 
imputecodes(3) 
   
 num.cases<-length(mdvector) # 51 
  
 random.numbers<-runif(num.cases,0,1) 
   
 ipovgp<-dataset$povgp 
  
 for (i in 1:num.cases) 
 { 
  icid<-mdvector[i] 
  impcode<-dataset[icid,157] 
   
  check<-sum(codeset==impcode) 
  if (check==0) 
  { 
   impcode<-searchcloseby(impcode,codeset) 
   } 
    
   subset<- 
dataset$id[is.na(dataset$povgpcode)==F&dataset$povgpcode==impcode&datas
et$povgpM==0] 
  k<-length(subset) 
   
  selected<-ceiling(k*random.numbers[i]) 
  ipovgp[icid]<-dataset[subset[selected],45] 
   
 } 
    
 dataout<-data.frame(data,ipovgp) 
 dataout 
 
 }   
  set.seed(100) 
   
 
# The other 119 subjects 
   
 
povgpimpute2<-function(dataset,dateout) 
{ 
 mdvector2<-
dataset$id[dataset$povgpM==1&is.na(dataset$povgpcode2)==F&is.na(dataset
$povgpcode)==T] # 119 obs 
  
 codeset2<-
dataset$povgpcode2[dataset$povgpM==0|dataset$povgpM==1&is.na(dataset$po
vgpcode)==F] # 320+51 obs 
  
 codeset2<-sort(codeset2) 
  
 num.cases2<-length(mdvector2)  
  
 random.numbers2<-runif(num.cases2,0,1) 
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 for (i in 1:num.cases2) 
 { 
  icid2<-mdvector2[i] 
  impcode2<-dataset[icid2,158] 
   
  impcode2<-searchcloseby(impcode2,codeset2) 
      
  subset2<-
dataset$id[dataset$povgpM==0&dataset$povgpcode2==impcode2|dataset$povgp
M==1&is.na(dataset$povgpcode)==F&dataset$povgpcode2==impcode2] 
  k2<-length(subset2) 
   
  selected2<-ceiling(k2*random.numbers2[i]) 
  dataset$ipovgp[icid2]<-
dataset[subset2[selected2],170] 
   
 } 
 dataout<-dataset$ipovgp 
 dataout 
} 
  
 set.seed(100) 
   
   
# total delay: 
 
totdlygpimpute<-function(dataset,dataout) 
{ 
 #dataset<-data 
 mdvector<-
dataset$id[dataset$totdlygpM==1&is.na(dataset$totdlygpcode)==F]  
   
 codeset<-dataset$totdlygpcode[dataset$totdlygpM==0]  
   
 codeset<-sort(codeset)  
    
 num.cases<-length(mdvector) 
  
 random.numbers<-runif(num.cases,0,1) 
   
 itotdlygp<-dataset$totdlygp 
  
 for (i in 1:num.cases) 
 { 
  icid<-mdvector[i] 
  impcode<-dataset[icid,159] 
   
  
  impcode<-searchcloseby(impcode,codeset) 
  
    
   subset<- 
dataset$id[is.na(dataset$totdlygpcode)==F&dataset$totdlygpcode==impcode
&dataset$totdlygpM==0] 
  k<-length(subset) 
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  selected<-ceiling(k*random.numbers[i]) 
  itotdlygp[icid]<-dataset[subset[selected],41] 
   
 } 
    
 dataout<-itotdlygp 
 dataout 
 
 }   
  set.seed(100) 
     
   
# Smoking History: 
 
smkhximpute<-function(dataset,dataout) 
{ 
 #dataset<-data 
  
 mdvector<-
dataset$id[dataset$smkhxM==1&is.na(dataset$smkhxcode)==F]  
   
 codeset<-dataset$smkhxcode[dataset$smkhxM==0]  
   
 codeset<-sort(codeset)  
    
 num.cases<-length(mdvector) 
  
 random.numbers<-runif(num.cases,0,1) 
   
 ismkhx<-dataset$SMKHX 
  
  
 for (i in 1:num.cases) 
 { 
  icid<-mdvector[i] 
  impcode<-dataset[icid,160] 
   
  
  impcode<-searchcloseby(impcode,codeset) 
  
    
   subset<- 
dataset$id[is.na(dataset$smkhxcode)==F&dataset$smkhxcode==impcode&datas
et$smkhxM==0] 
  k<-length(subset) 
   
  selected<-ceiling(k*random.numbers[i]) 
  ismkhx[icid]<-dataset[subset[selected],10] 
   
 } 
    
 dataout<-ismkhx 
 dataout 
 
 }   
  set.seed(100) 
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# Insurance: 
 
insgpimpute<-function(dataset,dataout) 
{ 
 #dataset<-data 
  
 mdvector<-
dataset$id[dataset$insgpM==1&is.na(dataset$insgpcode)==F]  
   
 codeset<-dataset$insgpcode[dataset$insgpM==0]  
   
 codeset<-sort(codeset)  
    
 num.cases<-length(mdvector) 
  
 random.numbers<-runif(num.cases,0,1) 
   
 iinsgp<-dataset$insgp 
  
  
 for (i in 1:num.cases) 
 { 
  icid<-mdvector[i] 
  impcode<-dataset[icid,161] 
   
  
  impcode<-searchcloseby(impcode,codeset) 
  
    
   subset<- 
dataset$id[is.na(dataset$insgpcode)==F&dataset$insgpcode==impcode&datas
et$insgpM==0] 
  k<-length(subset) 
   
  selected<-ceiling(k*random.numbers[i]) 
  iinsgp[icid]<-dataset[subset[selected],43] 
   
 } 
    
 dataout<-iinsgp 
 dataout 
 
 }   
  set.seed(100) 
   
      
# Education: 
 
educimpute<-function(dataset,dataout) 
{ 
 #dataset<-data 
  
 mdvector<-
dataset$id[dataset$educM==1&is.na(dataset$educcode)==F]  
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 codeset<-dataset$educcode[dataset$educM==0]  
   
 codeset<-sort(codeset)  
    
 num.cases<-length(mdvector) 
  
 random.numbers<-runif(num.cases,0,1) 
   
 ieduc<-dataset$educ 
  
  
 for (i in 1:num.cases) 
 { 
  icid<-mdvector[i] 
  impcode<-dataset[icid,162] 
   
  
  impcode<-searchcloseby(impcode,codeset) 
  
    
   subset<- 
dataset$id[is.na(dataset$educcode)==F&dataset$educcode==impcode&dataset
$educM==0] 
  k<-length(subset) 
   
  selected<-ceiling(k*random.numbers[i]) 
  ieduc[icid]<-dataset[subset[selected],46] 
   
 } 
    
 dataout<-ieduc 
 dataout 
 
 }   
  set.seed(100) 
   
      
#Oral contraceptive use:      
 
ocpimpute<-function(dataset,dataout) 
{ 
 #dataset<-data 
  
 mdvector<-
dataset$id[dataset$ocpM==1&is.na(dataset$ocpcode)==F]  
   
 codeset<-dataset$ocpcode[dataset$ocpM==0]  
   
 codeset<-sort(codeset)  
    
 num.cases<-length(mdvector) 
  
 random.numbers<-runif(num.cases,0,1) 
   
 iocp<-dataset$OCP 
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 for (i in 1:num.cases) 
 { 
  icid<-mdvector[i] 
  impcode<-dataset[icid,163] 
   
  
  impcode<-searchcloseby(impcode,codeset) 
  
    
   subset<- 
dataset$id[is.na(dataset$ocpcode)==F&dataset$ocpcode==impcode&dataset$o
cpM==0] 
  k<-length(subset) 
   
  selected<-ceiling(k*random.numbers[i]) 
  iocp[icid]<-dataset[subset[selected],26] 
   
 } 
    
 dataout<-iocp 
 dataout 
 
 }   
  set.seed(100) 
       
# Usual source of care: 
 
ucgpimpute<-function(dataset,dataout) 
{ 
 #dataset<-data 
  
 mdvector<-
dataset$id[dataset$ucgpM==1&is.na(dataset$ucgpcode)==F]  
   
 codeset<-dataset$ucgpcode[dataset$ucgpM==0]  
   
 codeset<-sort(codeset)  
    
 num.cases<-length(mdvector) 
  
 random.numbers<-runif(num.cases,0,1) 
   
 iucgp<-dataset$ucgp 
  
  
 for (i in 1:num.cases) 
 { 
  icid<-mdvector[i] 
  impcode<-dataset[icid,164] 
   
  
  impcode<-searchcloseby(impcode,codeset) 
  
    
   subset<- 
dataset$id[is.na(dataset$ucgpcode)==F&dataset$ucgpcode==impcode&dataset
$ucgpM==0] 
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  k<-length(subset) 
   
  selected<-ceiling(k*random.numbers[i]) 
  iucgp[icid]<-dataset[subset[selected],44] 
   
 } 
    
 dataout<-iucgp 
 dataout 
 
 }   
  set.seed(100) 
      
# Occupational class: 
 
occupimpute<-function(dataset,dataout) 
{ 
 #dataset<-data 
  
 mdvector<-
dataset$id[dataset$occupM==1&is.na(dataset$occupcode)==F]  
   
 codeset<-dataset$occupcode[dataset$occupM==0]  
   
 codeset<-sort(codeset)  
    
 num.cases<-length(mdvector) 
  
 random.numbers<-runif(num.cases,0,1) 
   
 ioccup<-dataset$occup 
  
  
 for (i in 1:num.cases) 
 { 
  icid<-mdvector[i] 
  impcode<-dataset[icid,165] 
   
  
  impcode<-searchcloseby(impcode,codeset) 
  
    
   subset<- 
dataset$id[is.na(dataset$occupcode)==F&dataset$occupcode==impcode&datas
et$occupM==0] 
  k<-length(subset) 
   
  selected<-ceiling(k*random.numbers[i]) 
  ioccup[icid]<-dataset[subset[selected],31] 
   
 } 
    
 dataout<-ioccup 
 dataout 
 
 }   
  set.seed(100) 
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# Comorbidity: 
 
comorbsimpute<-function(dataset,dataout) 
{ 
 #dataset<-data 
  
 mdvector<-
dataset$id[dataset$comorbsM==1&is.na(dataset$comorbscode)==F]  
   
 codeset<-dataset$comorbscode[dataset$comorbsM==0]  
   
 codeset<-sort(codeset)  
    
 num.cases<-length(mdvector) 
  
 random.numbers<-runif(num.cases,0,1) 
   
 icomorbs<-dataset$COMORBS 
  
  
 for (i in 1:num.cases) 
 { 
  icid<-mdvector[i] 
  impcode<-dataset[icid,166] 
   
  
  impcode<-searchcloseby(impcode,codeset) 
  
    
   subset<- 
dataset$id[is.na(dataset$comorbscode)==F&dataset$comorbscode==impcode&d
ataset$comorbsM==0] 
  k<-length(subset) 
   
  selected<-ceiling(k*random.numbers[i]) 
  icomorbs[icid]<-dataset[subset[selected],14] 
   
 } 
    
 dataout<-icomorbs 
 dataout 
 
 }   
  set.seed(100) 
    
        
# BMI: 
 
bmiqimpute<-function(dataset,dataout) 
{ 
 #dataset<-data 
  
 mdvector<-
dataset$id[dataset$bmiqM==1&is.na(dataset$bmiqcode)==F]  
   
 97 
 codeset<-dataset$bmiqcode[dataset$bmiqM==0]  
   
 codeset<-sort(codeset)  
    
 num.cases<-length(mdvector) 
  
 random.numbers<-runif(num.cases,0,1) 
   
 ibmiq<-dataset$BMIQ 
  
  
 for (i in 1:num.cases) 
 { 
  icid<-mdvector[i] 
  impcode<-dataset[icid,167] 
   
  
  impcode<-searchcloseby(impcode,codeset) 
  
    
   subset<- 
dataset$id[is.na(dataset$bmiqcode)==F&dataset$bmiqcode==impcode&dataset
$bmiqM==0] 
  k<-length(subset) 
   
  selected<-ceiling(k*random.numbers[i]) 
  ibmiq[icid]<-dataset[subset[selected],48] 
   
 } 
    
 dataout<-ibmiq 
 dataout 
 
 }   
  set.seed(100) 
     
# Patient delay: 
 
ptdlygpimpute<-function(dataset,dataout) 
{ 
 #dataset<-data 
  
 mdvector<-
dataset$id[dataset$ptdlygpM==1&is.na(dataset$ptdlygpcode)==F]  
   
 codeset<-dataset$ptdlygpcode[dataset$ptdlygpM==0]  
   
 codeset<-sort(codeset)  
    
 num.cases<-length(mdvector) 
  
 random.numbers<-runif(num.cases,0,1) 
   
 iptdlygp<-dataset$ptdlygp 
  
  
 for (i in 1:num.cases) 
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 { 
  icid<-mdvector[i] 
  impcode<-dataset[icid,168] 
   
  
  impcode<-searchcloseby(impcode,codeset) 
  
    
   subset<- 
dataset$id[is.na(dataset$ptdlygpcode)==F&dataset$ptdlygpcode==impcode&d
ataset$ptdlygpM==0] 
  k<-length(subset) 
   
  selected<-ceiling(k*random.numbers[i]) 
  iptdlygp[icid]<-dataset[subset[selected],40] 
   
 } 
    
 dataout<-iptdlygp 
 dataout 
 
 }   
  set.seed(100) 
    
      
           
#Therapy: 
 
therapyimpute<-function(dataset,dataout) 
{ 
 #dataset<-data 
  
 mdvector<-
dataset$id[dataset$therapyM==1&is.na(dataset$therapycode)==F]  
   
 codeset<-dataset$therapycode[dataset$therapyM==0]  
   
 codeset<-sort(codeset)  
    
 num.cases<-length(mdvector) 
  
 random.numbers<-runif(num.cases,0,1) 
   
 itherapy<-dataset$therapy 
  
  
 for (i in 1:num.cases) 
 { 
  icid<-mdvector[i] 
  impcode<-dataset[icid,169] 
   
  
  impcode<-searchcloseby(impcode,codeset) 
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   subset<- 
dataset$id[is.na(dataset$therapycode)==F&dataset$therapycode==impcode&d
ataset$therapyM==0] 
  k<-length(subset) 
   
  selected<-ceiling(k*random.numbers[i]) 
  itherapy[icid]<-dataset[subset[selected],63] 
   
 } 
    
 dataout<-itherapy 
 dataout 
 
 }   
  set.seed(100) 
        
 
n.iteration<-50 
nRow <- dim(data)[1] 
cols <- matrix(NA, nRow, 12*n.iteration) 
 
for (i in 1:n.iteration){ 
  
r<-12*(i-1)+1 
  
data2<-povgpimpute1(data) 
cols[,r]<-povgpimpute2(data2) 
cols[,r+1]<-totdlygpimpute(data) 
cols[,r+2]<-smkhximpute(data) 
cols[,r+3]<-insgpimpute(data) 
cols[,r+4]<-educimpute(data) 
cols[,r+5]<-ocpimpute(data) 
cols[,r+6]<-ucgpimpute(data) 
cols[,r+7]<-occupimpute(data) 
cols[,r+8]<-comorbsimpute(data) 
cols[,r+9]<-bmiqimpute(data) 
cols[,r+10]<-ptdlygpimpute(data) 
cols[,r+11]<-therapyimpute(data) 
   
 } 
  
write.csv(cols, file="/Users/Eva/Documents/idata+") 
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APPENDIX D 
COMPARISON OF THE DISTRIBUTIONS BETWEEN ORIGINAL UPDATED 
DATA AND IMPUTED DATA 
For total delay: 
 
 
Original 
 
 
 
Imputed 
 
 
 Total (N=320) 
White 
(N= 232) 
Black 
(N=88)  
Total 
(N=490) 
White 
(N=341) 
Black 
(N=149) 
Total 
delay 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
Total 
delay 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
0-<1m 36.99 36.03 39.39 0-<1m 39.39 39.59 38.93 
1-<3m 22.25 22.27 22.22 1-<3m 22.04 21.41 23.49 
3-<6m 15.03 15.38 14.14 3-<6m 14.29 14.37 14.09 
>=6m 25.72 26.32 24.24 >=6m 24.29 24.63 23.49 
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For smoking history 
 
 
Original 
 
 
 
Imputed 
 
 
 Total (N=320) 
White 
(N= 232) 
Black 
(N=88)  
Total 
(N=490) 
White 
(N=341) 
Black 
(N=149) 
Smoking 
History 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
Smoking 
History 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
never 58.22 54.92 66.36 never 58.57 55.13 66.44 
former 30.73 33.71 23.36 former 30.82 34.60 22.15 
currrent 11.05 11.36 10.28 currrent 10.61 10.26 11.41 
For type of insurance: 
 
 
Original 
 
 
 
Imputed 
 
 
 Total (N=320) 
White 
(N= 232) 
Black 
(N=88)  
Total 
(N=490) 
White 
(N=341) 
Black 
(N=149) 
Insurance 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) Insurance 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
none 7.28 4.55 14.02 none 9.18 5.87 16.78 
public 18.06 9.47 39.25 public 18.57 9.97 38.26 
any 74.66 85.98 46.73 any 72.24 84.16 44.97 
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 For education: 
For oral contraceptive use: 
 
Original 
 
 
 
Imputed 
 
 
 Total (N=320) 
White 
(N= 232) 
Black 
(N=88)  
Total 
(N=490) 
White 
(N=341) 
Black 
(N=149) 
Education 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) Education 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
<high 
school 29.65 19.32 55.14 
<high 
school 31.02 19.65 57.05 
high 
school 
graduate 32.61 34.85 27.10 
high 
school 
graduate 34.08 37.83 25.50 
>high 
school 37.74 45.83 17.76 
>high 
school 34.9 42.52 17.45 
 
 
Original 
 
 
 
Imputed 
 
 
 Total (N=320) 
White 
(N= 232) 
Black 
(N=88)  
Total 
(N=490) 
White 
(N=341) 
Black 
(N=149) 
Oral 
Contracep
-tive use 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
Oral 
Contracep
tive use 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
never used 78.44  74.62  87.85  never used 80.82  78.01  87.25 
used 21.56  25.38  12.15  used 19.18  21.99  12.75 
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For usual source of care: 
 
 
Original 
 
 
 
Imputed 
 
 
 Total (N=320) 
White 
(N= 232) 
Black 
(N=88)  
Total 
(N=490) 
White 
(N=341) 
Black 
(N=149) 
Usual 
source of 
care 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
Usual 
source of 
care 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
none 11.08 10.27 13.08 none 11.63 10.26 14.77 
public 10.54 2.66 29.91 public 11.43 2.05 32.89 
private 78.38 87.07 57.01 private 76.94 87.68 52.35 
For occupation class: 
 
 
Original 
 
 
 
Imputed 
 
 
 Total (N=320) 
White 
(N= 232) 
Black 
(N=88)  
Total 
(N=490) 
White 
(N=341) 
Black 
(N=149) 
Occupation 
Class 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
Occupation 
Class 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
manager/ 
profession 23.64 28.63 11.32 
manager/ 
profession 22.24 26.10 13.42 
technique/ 
sales 29.62 37.02 11.32 
technique/ 
sales 30.41 39.00 10.74 
skilled 
worker 20.38 14.50 34.91 
skilled 
worker 21.02 14.66 35.57 
unskilled 
worker 12.5 6.11 28.30 
unskilled 
worker 12.04 5.28 27.52 
homemaker 13.86 13.74 14.15 homemaker 14.29 14.96 12.75 
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 For comorbidities: 
 
 
Original 
 
 
 
Imputed 
 
 
 Total (N=320) 
White 
(N= 232) 
Black 
(N=88)  
Total 
(N=490) 
White 
(N=341) 
Black 
(N=149) 
Co-
morbidity 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
Co-
morbidity 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
no 28.31 34.54 14.89 no 29.59 35.78 15.44 
yes 71.69 65.46 85.11 yes 70.41 64.22 84.56 
For BMI: 
       
 
Original 
 
 
 
Imputed 
 
 
 Total (N=320) 
White 
(N= 232) 
Black 
(N=88)  
Total 
(N=490) 
White 
(N=341) 
Black 
(N=149) 
BMI 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) BMI 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
low 
normal 25.6 33.33 5.98 
low 
normal 25.31 34.02 5.37 
high 
normal 19.32 23.23 9.40 
high 
normal 18.78 22.87 9.40 
over-
weight 23.19 22.22 25.64 
over-
weight 23.88 21.99 28.19 
very over-
weight 31.88 21.21 58.97 
very over-
weight 32.04 21.11 57.05 
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 For patient delay: 
  
 
Original 
 
 
 
Imputed 
 
 
 Total (N=320) 
White 
(N= 232) 
Black 
(N=88)  
Total 
(N=490) 
White 
(N=341) 
Black 
(N=149) 
Patient 
Delay 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
Patient 
Delay 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
no 6.98 8.63 2.91 no 5.92 7.62 2.01 
0-<1m 59.78 60.78 57.28 0-<1m 61.02 61.58 59.73 
1-<3m 13.41 12.94 14.56 1-<3m 12.86 11.73 15.44 
3-<6m 8.1 7.45 9.71 3-<6m 7.76 7.33 8.72 
>=6m 11.73 10.20 15.53 >=6m 12.45 11.73 14.09 
For treatment: 
 
 
Original 
 
 
 
Imputed 
 
 
 Total (N=320) 
White 
(N= 232) 
Black 
(N=88)  
Total 
(N=490) 
White 
(N=341) 
Black 
(N=149) 
Treatment 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) Treatment 
Frequency 
(%) 
Frequency 
(%) 
Frequency 
(%) 
no surgery 12.53 5.35 27.86 no surgery 12.04 5.57 26.85 
only 
surgery 43.28 49.50 30.00 
only 
surgery 44.49 49.85 32.21 
surgery+ 44.19 45.15 42.14 surgery+ 43.47 44.57 40.94 
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